https://www.sukl.sk/o-nas 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov 2026-03-31 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku 2020-12-09 weekly https://www.sukl.sk/o-nas/databazy-a-servis 2026-04-08 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty 2026-04-08 weekly https://www.sukl.sk/o-nas/o-sukl/historia-a-sucasnost 2026-04-08 weekly https://www.sukl.sk/o-nas/spolupraca/medzinarodna-spolupraca 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/zakladne-dokumenty/zriadovacia-listina-statut 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/zakladne-dokumenty/organizacny-poriadok 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy 2026-04-08 weekly https://www.sukl.sk/o-nas/poradne-organy/komisia-pre-lieky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov 2026-03-12 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/kontakt 2026-03-20 weekly https://www.sukl.sk/aktuality-1 2026-03-20 weekly https://www.sukl.sk/hlasenie-o-neziaducich-ucinkoch 2026-03-20 weekly https://www.sukl.sk/bezpecnostne-opatrenia-a-upozornenia 2026-03-20 weekly https://www.sukl.sk/formulare-1 2026-03-20 weekly https://www.sukl.sk/bulletin 2026-03-20 weekly https://www.sukl.sk/kontakt 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/vyhladavanie-liekov-zdravotnickych-pomocok-a-zmien-v-liekovej-databaze 2026-04-08 weekly https://www.sukl.sk/sk/servis/mapa-stranok 2007-01-02 weekly https://www.sukl.sk/o-nas/databazy-a-servis/linky 2026-04-01 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/vyhladavanie-liekov-zdravotnickych-pomocok-a-zmien-v-liekovej-databaze/vyhladavanie-na-strankach 2026-04-15 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/vyhladavanie-liekov-zdravotnickych-pomocok-a-zmien-v-liekovej-databaze/vyhladavanie-v-databaze-registrovanych-liekov 2026-04-15 weekly https://www.sukl.sk/sk/o-nas/legislativa 2026-04-08 weekly https://www.sukl.sk/o-nas/verejne-obstaravanie 2026-04-08 weekly https://www.sukl.sk/o-nas/poskytovanie-informacii 2026-04-01 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/skolenia-a-kurzy-seminare-v-roku-2006 2026-03-20 weekly https://www.sukl.sk/o-nas/regionalne-pracoviska 2026-04-01 weekly https://www.sukl.sk/kontakty/uradne-hodiny 2026-04-01 weekly https://www.sukl.sk/test1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/poradne-organy/slovenska-liekopisna-komisia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/poradne-organy/komisia-pre-bezpecnost-lieciv 2026-03-20 weekly https://www.sukl.sk/en/databases-and-services/other-lists/list-of-pharmacies 2026-03-20 weekly https://www.sukl.sk/en/databases-and-services/other-lists/list-of-medicines-wholesalers 2026-03-20 weekly https://www.sukl.sk/en/databases-and-services/other-lists/list-of-medicine-manufacturing-authorization-holders 2026-03-20 weekly https://www.sukl.sk/en/databases-and-services/other-lists/list-of-registered-medical-devices 2026-03-20 weekly https://www.sukl.sk/en/servis/search/searching-on-the-database-of-medicinal-products 2026-04-15 weekly https://www.sukl.sk/en/servis/search/searching-on-the-web 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/zdravotnicke-pomocky 2026-04-08 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/stanovisko-sukl-k-bezpecnosti-lieku-ketek-telitromycin-30-1-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/stanovisko-sukl-k-bezpecnosti-nespecifickych-nesteroidnych-protizapalovych-liekov-nsaids-26-9-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/stanovisko-sukl-k-roztoku-na-kontaktne-sosovky-renu-moistureloc-18-5-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/stanovisko-sukl-ku-stiahnutiu-sarze-liekov-neolutin-forte-inj-a-methylergometrin-spofa-21-6-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/stanovisko-sukl-rastlinne-lieky-s-obsahom-cimicifuga-racemosae-rhizoma-18-7-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/stanovisko-sukl-k-uvadzaniu-vyrobkov-s-obsahom-freonov-na-trh-v-sr-4-8-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/t-stanovisko-sukl-k-bezpecnosti-protichripkovych-vakcin-24-10-2006- 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2006/t-stanovisko-sukl-k-bezpecnosti-neselektivnych-nesteroidnych-protizapalovych-liekov-24-10-2006- 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/zakladne-dokumenty/organizacna-struktura 2026-04-08 weekly https://www.sukl.sk/sk/o-nas/von-pracovn-miesta-2/von-miesta-v-ttnej-slube-2 2026-03-20 weekly https://www.sukl.sk/sk/o-nas/volne-pracovne-miesta-2/volne-pracovne-miesta-pre-prace-vo-verejnom-zaujme-0 2026-03-20 weekly https://www.sukl.sk/sk/o-nas/legislativa/pravne-predpisy-sr 2026-04-08 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky-informacie 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/zdravotnicke-pomocky/postupy 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/hlasenie-podozreni-na-neziaduce-ucinky-liekov 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia 2020-05-27 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny 2018-07-23 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko 2026-04-08 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-bezpecnosti-nespecifickych-nesteroidnych-protizapalovych-liekov-nsaids- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-k-bezpecnosti-liekov-elidel-pimecrolimus-a-protopic/protopy-tacrolimus- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-bezpecnosti-lieku-ketek-telitromycin- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-pozastaveniu-registracie-vakciny-hexavac 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/ucinnost-a-bezpecnost-sucasneho-podavania-tenofovir-dizoproxil-fumaratu-a-didanozinu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/oznam-o-novych-regulacnych-opatreniach-u-cox-2-inhibitorov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacia-pre-verejnost-klimakterium-a-hormonalna-liecba 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-bezpecnosti-hormonalnej-substitucnej-terapie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-25/2005 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-24/2004 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-23/2004 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-bezpecnosti-neselektivnych-nesteroidnych-protizapalovych-liekov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-bezpecnosti-protichripkovych-vakcin 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/pokyny 2020-09-03 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/uzitocne-linky 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/linky 2025-09-11 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-22/2003 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-21/2003 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-20/2002 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-19/2002 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-18a/2001 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-18/2001 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-17/2001 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-16/2000 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-15/1999 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-14/1998 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/paroxetin-kontraindikacia-u-deti-pod-18-rokov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/kontraindikacia-sucasneho-pouzivania-repaglinidu-a-gemfibrozilu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/preventivne-opatrenia-pri-pouzivani-telithromycinu-ketek-u-pacientov-s-myasteniou-gravis 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/riziko-zavaznej-hypersenzitivity-a-koznych-reakcii-po-pripravkoch-s-obsahom-parekoxibu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/ockovanie-proti-chripke 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-v-r-2006-a-starsie/pripravky-s-obsahom-kava-kava-piper-methysticum 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-v-r-2006-a-starsie/epoetin-erytroblastopenia 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-emea-k-infliximabu-remicade- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-emea-k-infliximabu-remicade--1 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/upozornenie-statneho-ustavu-pre-kontrolu-lieciv-o-novych-neziaducich-ucinkoch-pripravku-infliximab-remicade- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/riziko-antikoncepcie-oralnymi-kontraceptivami-tretej-generacie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/riziko-antikoncepcie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/dolezite-informacie-ktore-by-sa-mali-uviest-v-spc-a-v-informaciach-pre-pouzivatela-u-vsetkych-monokomponentnych-pripravkoch-s-obsahom-lubovnika-bodkovaneho-alebo-extraktov-z-neho 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/upozornenie-na-kozne-a-hepatalne-neziaduce-ucinky-nevirapinu-viramun- 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory 2026-04-08 weekly https://www.sukl.sk/sk/drogove-prekurzory/aktuality- 2006-12-19 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/zakon-c.-331-2005-z.-z.-o-organoch-statnej-spravy-vo-veciach-drogovych-prekurzorov 2026-03-20 weekly https://www.sukl.sk/kontakty/bankove-spojenie 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/linky 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/ako-postupovat-pri-podozreni-na-nekvalitu-lieku 2026-04-15 weekly https://www.sukl.sk/sk/posudzovanie-kvality-liekov/faq 2026-04-08 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/cko-faq 2026-04-08 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-49-/-2006 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-48-/-2006 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-47-/-2006 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-46-/-2005 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-45-2005 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-44-2005 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-43-2005 2006-12-28 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-42-2004 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-41-2004 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-40-2004 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-39-2003 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-38-2003 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-37-2003 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-36-2003 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-35-2002 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-34-2002 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-33-2002 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-32-2002 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-31-2001 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-30-2001 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-29-2001 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-28-2000 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-27-2000 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-26-2000 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-25-2000 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-24-1999 2007-01-17 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-23-1999 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-22-1999 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-21-1999 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-20-1998 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-19-1998 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-18-1998 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-17-1998 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-16-1997 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-15-1997 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-14-1997 2006-12-29 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/archiv-sprav-o-kvalite-lieciv/sokl-13-1997 2006-12-29 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/vyhlaska-mh-sr-c.-380-2005-podavanie-hlaseni 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/skolenia-a-kurzy-seminare-v-roku-2007 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/gadoliniove-kontrastne-latky 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/liekove-riziko/liekove-riziko-26/2005 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-27-2006 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/faq 2020-12-09 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2007/tlacova-sprava-kpl-17-1-2007 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/ine-zariadenia/ocne-optiky 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/ine-zariadenia/pestovatelia-maku 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/ine-zariadenia/ine-zdravotnicke-zariadenia 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-50-2006 2007-01-29 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/prehlady/trvanie-schvalovacieho-procesu-klinickeho-skusania-v-roku-2006 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/mam-moj-produkt-registrovat-ako-liek/liek-alebo-zdravotnicka-pomocka 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/mam-moj-produkt-registrovat-ako-liek/liek-alebo-vyzivovy-doplnok 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/mam-moj-produkt-registrovat-ako-liek/liek-alebo-kozmetika 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/zakladne-informacie-o-registracii-lieku 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/registracia-lieku/dokumentacia-k-registracii-lieku-preukazanie-kvality-ucinnosti-a-bezpecnosti-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/typy-ziadosti-o-registraciu-lieku-podla-pravneho-zakladu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/posudenie-ziadosti-o-registraciu 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/mam-moj-produkt-registrovat-ako-liek/co-je-to-liek 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/tradicne-rastlinne-lieky/co-je-to-tradicny-rastlinny-liek 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/tradicne-rastlinne-lieky/ziadost-o-registraciu-tradicneho-rastlinneho-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/tradicne-rastlinne-lieky/zamietnutie-ziadosti-o-registraciu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/tradicne-rastlinne-lieky/ostatne-pokyny-a-poziadavky-na-registraciu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/tradicne-rastlinne-lieky/specificke-pokyny-k-dokumentacii 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/homeopatika/co-je-to-homeopaticky-liek 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/homeopatika/ziadost-o-registraciu-homeopatickeho-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/homeopatika/zjednoduseny-registracny-postup 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/homeopatika/ostatne-pokyny-a-poziadavky-na-registraciu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/homeopatika/specificke-pokyny-k-dokumentacii 2026-03-20 weekly https://www.sukl.sk/sk/servis/vyhladavanie-databazy/zoznam-registrovanych-liekov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/kriteria-na-vyhodnotenie-stupna-pricinnosti-neziaducej-reakcie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/potvrdenie-zavaznej-neziaducej-reakcie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/oznamenie-zavaznej-neziaducej-udalosti 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/vyrocna-sprava-o-zavaznych-neziaducich-reakciach 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/potvrdenie-zavaznej-neziaducej-udalosti 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/vyrocna-sprava-o-zavaznych-neziaducich-udalostiach 2026-03-20 weekly https://www.sukl.sk/en/about-sidc/advisory-bodies/committee-for-drug-safety 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2003 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2004 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2005 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/news/commission-regulation-ec-no-1277-2005 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/advisory-bodies/pharmacopoeia-committee 2026-03-20 weekly https://www.sukl.sk/en/databases-and-services/other-lists/list-of-registered-medicinal-products 2026-03-20 weekly https://www.sukl.sk/en/databases-and-services/other-lists/list-of-authorised-laboratories 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/annex-no.-23-to-the-marketing-authorization-application 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-2006 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-2007 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/mam-moj-produkt-registrovat-ako-liek/liek-alebo-dieteticka-potravina 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/posobnost/posobnost-a-rozsah-cinnosti-sekcie-inspekcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/posobnost/posobnost-jednotlivych-referatov-oddelenia-kontroly-distribucie-liekov-a-lekarenstva 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/ulohy-sekcie-laboratornej-kontroly 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/poradne-organy/subkomisia-pre-fytofarmaka-a-homeopatika 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/medzinarodna-spolupraca/europska-liekova-agentura-ema 2026-03-12 weekly https://www.sukl.sk/sk/inspekcia/legislativa/nariadenie-vlady-324/2006-o-odbornej-sposobilosti-doplnenie-742/2004 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/legislativa/vyhlaska-mz-sr-396/2005-o-rozsahu-priameho-dodavania-liekov-a-zp 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/legislativa/vyhlaska-mz-sr-c-475/2005-o-kusovej-evidencii-liekov-a-zp 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/legislativa/vyhlaska-mz-sr-c-507/2005-o-povolovani-terapeutickeho-pouzitia-hvlp 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/legislativa/zakon-139/1998-z-z-o-omamnych-psychotropnych-latkach-a-pripravkoch 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/medzinarodna-spolupraca/heads-of-medicines-agencies-hma 2026-03-12 weekly https://www.sukl.sk/sk/o-nas/medzinarodna-spolupraca/europska-komisia 2026-03-12 weekly https://www.sukl.sk/sk/o-nas/medzinarodna-spolupraca/pic-scheme 2026-03-12 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/medzinarodna-spolupraca/edqm 2026-03-12 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/ine-zariadenia/vstupne-inspekcie-doklady 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/lekarenstvo/vstupne-inspekcie-doklady 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/distribucia/doklady-potrebne-pre-vykonanie-vstupnej-inspekcie 2026-04-15 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2007/tlacova-sprava-kpl-02/2007 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2007/tlacova-sprava-kpl-03/2007 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy2007/tlacova-sprava-subkomisia-pre-fytofarmaka-a-homeopatika-02/2007 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-sukl-k-pouzivaniu-lieku-ketek 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy2007/stanovisko-sukl-k-pouzivaniu-lieku-ketek 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/ine-zariadenia/formulare 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/posobnost/referaty 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy2006/falosne-lieky-na-internete 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-51-2007 2007-04-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-emea-ku-kardiovaskularnej-bezpecnosti-rosiglitazonu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-k-pozastaveniu-distribucie-lieku-euvax-20-ug 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/oznam-o-preverovani-hepatotoxickych-ucinkov-nimesulidu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/oznamenie-europskej-liekovej-agentury-o-stiahnuti-lieku-viracept 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-tykajuce-sa-stiahnutia-lieku-viracept 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-o-naslednych-krokoch-po-stiahnuti-lieku-viracept 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/odporucanie-europskej-liekovej-agentury-na-obmedzene-pouzivanie-piroxikamu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-tykajuce-sa-prehodnotenia-piroxikamu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-k-uvolneniu-lieku-euvax-20-mcg-do-distribucie 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-52-2007 2007-07-18 weekly https://www.sukl.sk/sk/media/tlacove-spravy2007/tlacova-sprava-kpl-04-2f2007 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy2007/tlacova-sprava-kpl-05-2f2007 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy2007/tlacova-sprava-kpl-06-2f2007 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy2007/tlacova-sprava-07-2f2007 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovedeo-bezpecnosti-lieku-acomplia 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/stanovisko-emea-k-lieku-acomplia 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-k-stiahnutiu-lieku-haemate-p-500-iu-z-distribucie 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/rss 2026-04-01 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-28-2006 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-29-2007 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-30-2007 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-tykajuce-sa-stiahnutia-lieku-cisplatin-96-teva-con-inf-1-x-10-ml-2f10-mg 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/tlacova-sprava-o-obmedzeni-pouzivania-pripravkov-s-obsahom-nimesulidu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-o-odporucaniach-chmp-o-liekoch-s-obsahom-nimesulidu 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/duration-of-approval-process-in-2006 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/list-of-approved-clinical-trials-in-2006 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/number-of-clinical-trials-in-2006 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/sidc-guidance-on-the-processing-of-type-ia-and-ib-notifications 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-53-2007 2007-10-23 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/tlacova-sprava-o-pozitivnych-prinosoch-reosiglitazonu-a-pioglitazonu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-tykajuce-sa-prinosov-a-rizik-pri-uzivani-rosiglitazonu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/tlacova-sprava-kontaminovane-anestetikum-v-nsp-levice 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/tlacova-sprava-epoetiny-a-riziko-progresie-rastu-nadoru 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/linky 2026-04-08 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/tlacova-sprava-zmeny-v-spc-lieku-protelos-2fosseor 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-tykajuce-sa-bezpecnosti-liekov-protelos-2fosseor 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2006 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacia-o-prehodnoteni-bezpecnosti-pouzivania-liekov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacia-o-docasnom-pozastaveni-distribucie-lieku-gordox-na-slovensky-trh 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/upozornenie-sukl-pouzivanie-propofolu- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/champix-96-samovrazedne-myslienky-a-a0samovrazedne-pokusy 2026-03-20 weekly https://www.sukl.sk/en/about-sidc/co-operation-international/comments-to-commision-regulation-proposal-concerning-the-examination-of-variations-in-marketing-authorisation-and-registration-dossier 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/pokyny/informacia-pre-distribucne-organizacie-o-a0zasobovani-liekmi-s-a0obsahom-dp 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/spravy-o-kvalite-lieciv/sokl-54-2007 2008-01-29 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/oznam-sukl-o-novych-upozorneniach-a-kontraindikaciach-pre-rosiglitazon 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/upozornenie-sukl-gardasil-96-najnovsie-informacie 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/vyhladavanie-liekov-zdravotnickych-pomocok-a-zmien-v-liekovej-databaze/vyhladavanie-v-databaze-zdravotnickych-pomocok 2026-04-15 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/sebivo-96-najnovsie-informacie-o-bezpecnosti 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/list-of-approved-clinical-trials-in-2007 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/duration-of-approval-process-in-2007 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/reakcia-sukl-na-tlacovu-spravu-fda-o-stiahnuti-heparin-sodium-injection 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-31-2008 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/nova-kontraindikacia-u-a0lieku-velcade-bortezomib- 2026-03-20 weekly https://www.sukl.sk/vyhladavanie-v-databaze-registrovanych-liekov 2026-03-20 weekly https://www.sukl.sk/vyhladavanie-v-databaze-zdravotnickych-pomocok 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/vyhladavanie-v-databazach-registrovanych-liekov-a-zdravotnickych-pomocok/archiv-zmien-v-registracnej-databaze-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/databazy-a-servis/vyhladavanie-liekov-zdravotnickych-pomocok-a-zmien-v-liekovej-databaze/archiv-zmien-v-registracnej-databaze-liekov 2026-04-15 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/archiv 2026-03-20 weekly https://www.sukl.sk/o-nas/databazy-a-servis/ine-zoznamy 2008-04-09 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-32-2008 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola/spravy-o-kvalite-lieciv/sokl-55-2f-2008 2008-05-16 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/doplnujuca-informacia-o-stiahnuti-lieciveho-pripravku-nurofen-pre-deti-capiky-60-mg-rct-sup-10-x-60-mg 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/pokyny-es-k-spravnej-vyrobnej-praxi-good-manufacturing-practice-gmp-guidelines 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-2008 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/reakcia-sukl-na-vyzvu-pz-sr-v-suvislosti-s-pripravkom-restimosol-na-onkologicku-liecbu 2026-03-20 weekly https://www.sukl.sk/en/quality-assessement-of-medical-products/pharmacopoeia/reference-names-of-drug-forms-in-human-medicine 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/epoetiny-96-nove-odporucanie-pre-pouzitie-u-onkologickych-pacientov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/norfloxacin-p-o-96-zrusenie-indikacie-na-liecbu-komplikovanej-pyelonefritidy 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/moxifloxacin-pre-peroralne-pouzitie-96-obmedzenie-pouzivania 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola/spravy-o-kvalite-lieciv/sokl-56-2f-2008 2008-08-18 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/antiepileptika-96-vysledok-analyzy-bezpecnosti-liekov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-33-2008 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/legislativa/pokyny-pre-spravnu-distribucnu-prax-humannych-liekov 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola/prerusenia-dodavok-liekov-v-sr 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/europska-liekova-agentura-odporuca-pozastavenie-registracie-pre-liek-acomplia- 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-kvality/spravy-o-kvalite-lieciv/sokl-57-2008 2022-04-05 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/stretnutie-zastupcov-sukl-a-drzitelov-registracie 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/oznam-o-zmenach-v-registracii-liekov-s-obsahom-pseudoefedrinu 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/gardasil-96-dva-pripady-neziaducich-ucinkov-v-a0spanielsku 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/sprava-raptiva 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/nove-autolekarnicky-tlacova-beseda-na-mz-sr 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/twinningovy-projekt-v-turecku 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/europsky-audit-bema 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/prestahovanie-kontrolneho-laboratoria-kosice 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/skolenie-szu-na-temu-priprava-radiofarmak 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/procesny-audit-na-sukl 2026-03-20 weekly https://www.sukl.sk/sk/media/tlacove-spravy-2009/vizia-riaditela-sukl-pre-rok-2009 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/spravy-2009/podakovanie-za-dlhorocnu-spolupracu 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/prehliadace-formatov/prehliadac-pre-subory-microsoft-word-doc- 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/prehliadace-formatov/prehliadac-pre-subory-microsoft-excel-xls- 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/prehliadace-formatov/prehliadac-pre-subory-microsoft-powerpoint-ppt- 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/prehliadace-formatov/prehliadac-pre-subory-acrobat-portable-document-format-pdf- 2026-03-20 weekly https://www.sukl.sk/o-nas/databazy-a-servis/prehliadace-formatov/balik-kompatibility-balika-microsoft-office-pre-subory-vo-formate-programu-word-excel-a-powerpoint-2007 2026-03-20 weekly https://www.sukl.sk/sk/databazy-a-servis/prehliadace-formatov/aktualizacia-balika-kompatibility-microsoft-office-compatibility-pack-service-pack-1-sp1- 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2007 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/doplnok-1-k-pokynom-es-k-spravnej-vyrobnej-praxi-vyroba-sterilnych-liekov 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-2009 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/duration-of-approval-process-in-2008 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/aktualna-informacia-sukl-o-situacii-v-suvislosti-s-novym-typom-virusu-chripky 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/aktualna-informacia-sukl-zo-dna-5-5-2009-o-situacii-v-suvislosti-s-novym-typom-virusu-chripky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/predlzenie-doby-pouzitelnosti-lieku-tamiflu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2008 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacia-sukl-zrusenie-registracie-lieku-raptiva-efalizumab- 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/spravy-2009/oznam-o-uverejneni-vyrocnej-spravy-o-cinnosti-sukl-za-rok-2008 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/emea-doporucuje-prednostny-pristup-k-liekom-cerezyme-a-fabrazyme-pre-urcite-skupiny-pacientov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacia-o-bezpecnosti-inzulinu-glargin 2026-03-20 weekly https://www.sukl.sk/en/inspection/alerts/special-announcements 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality 2026-04-08 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/oznamy/oznam-pre-zdravotnicke-zariadenia-v-sr-ohladne-pristrojov-od-subjektu-ing.-andrej-dzadon-medservis 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/oznamy/aktualna-informacia-o-postupe-sukl-v-procese-registracie-diagnostickych-zdravotnickych-pomocok-in-vitro-od-vyrobcu-ing.-andrej-dzadon-medservis 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc 2021-04-13 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/informacia-ohladom-suvislosti-medzi-podavanim-cellcept-a-izolovanej-aplazie-cervenych-krviniek 2026-03-20 weekly https://www.sukl.sk/sk/o-ns/poradn-orgny/subkomisia-pre-generick-lieky 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cerezyme-c2-ae-imigluceraza-aktualizacia-docasnych-odporucani-na-liecbu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/interakcia-inhibitorov-protonovej-pumpy-s-klopidogrelom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/spravy-2009/subkomisia-pre-genericke-lieky 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/europska-liekova-agentura-odporuca-registraciu-dvoch-a-h1n1-v-pandemickych-vakcin 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/fabrazyme-agalzidaza-beta-e2-80-93-aktualizacia-docasnych-odporucani-na-liecbu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/nove-odporucania-pre-pouzivanie-liekov-cerezyme-a-fabrazyme-pri-ich-pokracujucom-nedostatku 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/europska-liekova-agentura-odporucila-registraciu-dalsej-vakciny-proti-pandemickej-chripke-a-h1n1-v 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/intelence-etravirinum-e2-80-93-toxicka-epidermalna-nekrolyza-a-dress-syndrom 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/relenza-zanamivir-upraveny-inhalacny-prasok-nesmie-byt-nebulizovany- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/tamiflu-oznam-lekarnikom 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/mabthera-e2-80-93-progresivna-multifokalna-encefalopatia-u-pacientov-liecenych-na-reumatoidnu-artritidu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/tamiflu-oznam-lekarom 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/tamiflu-e2-80-93-nove-pokyny-pre-davkovanie-u-deti-do-12-mesiacov-zivota-a-na-pripravu-davky-pre-dieta-ak-nie-su-k-dispozicii-liekove-formy-vhodne-pre-deti 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-potvrdila-ucinnost-a-bezpecnost-pandemickych-vakcin 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacie-o-pandemickych-vakcinach-pouzivanych-v-eu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacie-o-dalsich-vakcinach-registrovanych-v-sr 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/stvrtrocne-hlasenie-drzitela-povolenia-na-vyrobu-liekov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/dna-10-12-2009-vydal-sukl-rozhodnutie-o-registracii-pandemickej-vakciny-panenza 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacie-o-pandemickych-vakcinach-pouzivanych-v-eu-1 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/fabrazyme-e2-80-93-pritomnost-cudzorodych-castic-a-aktualizacia-informacii-o-zasobovani 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cerezyme-e2-80-93-pritomnost-cudzorodych-castic-a-aktualizacia-informacii-o-zasobovani 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/thyrogen-e2-80-93-pritomnost-cudzorodych-castic-a-aktualizacia-informacii-o-zasobovani 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/oznamy/informacia-o-diagnostickych-zp-in-vitro-od-vyrobcu-ing.-andrej-dzadon-medservis 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/informacia-o-ortutovych-teplomeroch 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacie-o-pandemickych-vakcinach-pouzivanych-v-eu-2 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/upozornenie-pre-uzivatelov-liekov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacia-o-naleze-balenia-lieku-s-nespravnym-obsahom-tabliet 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacie-o-pandemickych-vakcinach-pouzivanych-v-eu-3 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/stiahnutie-lieku-fluorescein 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/distribucia/zoznam-vydany-osvedceni-o-dodrziavani-spravnej-velkodistribucnej-praxe 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/nurofen-pre-deti-jahoda-informacia-k-rozhodnutiu-o-stiahnuti-lieku-z-trhu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/informacie-o-pandemickych-vakcinach-pouzivanych-v-eu-4 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-34-2009 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-pozastavit-registraciu-liekov-s-obsahom-ucinnej-latky-sibutramin 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-pozastavenie-registracie-liekov-s-obsahom-sibutraminu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/nove-odporucania-pre-liecbu-liekom-tysabri-natalizumab- 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pozastavenie-registracie-reductil 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/announcement-for-applicants-marketing-authorization-holders-procedure-in-relation-to-commisiion-regulation-ec-no.-1234-2008-concerning-the-variation-to-the-terms-of-ma 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/upozornenie-pre-spotrebitelov-na-slovensku-na-zdravotne-rizika-spojene-s-dlhodobym-nadmernym-pouzivanim-fixacneho-kremu-na-zubne-nahrady-corega-extra-silny 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/alli-pankreatitida-oxalatova-nefropatia-a-interakcie-s-levotyroxinom-a-antiepileptikami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/bezpecne-pouzivanie-masti-protopic-a-sledovanie-priebehu-liecby 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/monitorovanie-terapie-liekom-rapamune-c2-ae-sirolimus- 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/register-subjektov-s-povolenim-na-zasielkovy-vydaj/zoznam-vydajni-zdravotnickych-pomocok-ktorym-bol-vydany-posudok-sukl-na-zasielkovy-vydaj 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-2010 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/vyhlaska-mz-sr-ktorou-sa-ustanovuju-podrobnosti-o-zasielkovom-vydaji-liekov-a-zdravotnickych-pomocok 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/poskodenie-funkcie-obliciek-po-aclaste-kyselina-zolendronova-5-mg-infuzny-roztok- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cerezyme-c2-ae-imigluceraza-dalsie-meskania-dodavok-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fabrazyme-agalsidase-beta-dalsie-meskania-dodavok-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny/zmeny-v-smpc-a-pil-odsuhlasene-phv-wp-a-cmdh-na-implementaciu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/rotarix-ema-neidentifikovala-v-suvislosti-s-pouzivanim-vakciny-rotarix-ziadne-bezpecnostne-rizika 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacie-sukl-ku-stahovaniu-niektorych-liekov-s-obsahom-klopidogrelu 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/informacia-o-nehodach-poruchach-zlyhaniach-silikonom-plnenych-prsnikovych-implantatov-typu-imghc-tx-imghc-mx-imghc-ls-od-vyrobcu-poly-implant-prosthese-francuzsko 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/tysabri-natalizumab-e2-80-93-progresivna-multifokalne-leukoencefalopatia 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-zrusit-registraciu-liekov-s-obsahom-lieciva-bufexamak 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/vectibix-panitumumab-e2-80-93-hypersenzitivne-reakcie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/exelon-2f-prometax-rivastigmin-e2-80-93-chybne-pouzitie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cerezyme-c2-ae-imigluceraza-dalsie-meskania-dodavok-lieku-1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fabrazyme-agalsidaza-beta-dalsie-meskania-dodavok-lieku 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/nimesulid-e2-80-93-druholiniova-liecba-skratenie-liecby-na-15-dni-podavanie-s-hepatotoxickymi-liekmi-podavanie-pri-horucke 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/avastin-bevacizumab-e2-80-93-reakcie-z-precitlivenosti-a-reakcie-na-infuziu 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2009 2022-04-05 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2008 2013-09-11 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2007 2013-09-11 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2006 2022-04-05 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2005 2013-09-11 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2004 2013-09-11 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2003 2013-09-11 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2002 2013-09-11 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2001 2013-09-11 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/informacia-o-nehode-poruche-zlyhani-implantovatelneho-defibrilatora-lumax-340-vr-t-od-vyrobcu-biotronik-se-co.-kg-nemecko 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/risperdal-consta-risperidon-e2-80-93-problemy-s-pripojenim-ihly 2026-03-20 weekly https://www.sukl.sk/en/about-sidc/seminars-presentations/communication-in-drug-safety-approach-of-state-institute-for-drug-control 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/aktualizacia-informacie-o-nehode-poruche-zlyhani-implantovatelneho-defibrilatora-lumax-340-vr-t-od-vyrobcu-biotronik-se-co.-kg-nemecko 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny 2026-04-15 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/vfend-vorikonazo-e2-80-93-hepatalne-neziaduce-ucinky 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/keppra-levetiracetam-e2-80-93-hepatalne-neziaduce-ucinky 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cerezyme-c2-ae-imigluceraza-dalsie-oneskorenie-normalneho-zasobovania-liekom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fabrazyme-agalsidaza-beta-aktualna-informacia-o-dodavkach-a-odporucani-pre-liecbu-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/vakciny/sposobuju-vakciny-diabetes-mellitus-i.typu-otazky-a-odpovede 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-potvrdila-prevahu-prinosu-nad-rizikami-u-lokalne-podavanych-liekov-s-obsahom-ketoprofenu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-o-celoeuropskom-prehodnoteni-liekov-s-obsahom-ketoprofenu-na-lokalne-podanie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/avandia-avandamet-a-avaglim-e2-80-93-aktualne-informacie-o-prehodnocovani-pomeru-ucinok-2friziko-v-europskej-liekovej-agenture 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-odporuca-obmedzenie-uzivania-modafinilu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-35-2010 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/duration-of-approval-proces-2009 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/instructions/labelling-requirements-for-investigational-medicinal-product 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/ketoprofen-na-lokalne-pouzitie-e2-80-93-opatrenia-na-znizenie-rizik 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/spravna-prax-pripravy/podmienky-pre-vydanie-posudku-sukl 2026-03-20 weekly https://www.sukl.sk/sk/o-nas/zmluvy-za-sukl/zmluvy-platne-a-ucinne-k-9-julu-2010-vratane-viazanych-rozpoctovych-prostriedkov-na-ich-plnenie-v-ii-polroku-2010 2026-03-20 weekly https://www.sukl.sk/sk/o-nas/zmluvy-za-sukl/zmluvy-ktorych-platnost-skoncila-v-obdobi-do-9-jula-2010 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/stiahnutie-z-distribucie-lieku-vigantol 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/vigantol-vitamin-d3-e2-80-93-stiahnutie-lieku-od-distributorov 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/spravna-prax-pripravy/podmienky-pre-vydanie-osvedcenia-sukl 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cardioxane-dexrazoxan-e2-80-93-riziko-druhych-malignit-u-deti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/relistor-injekcny-roztok-metylnatrexoniumbormid-hlasenia-gastrointestinalnej-perforacie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/abseamed-c2-ae-injekcny-roztok-v-naplnenych-injekcnych-striekackach-informacie-ohladom-bezpecneho-pouzivania 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/lieky-na-liecenie-diabetes-mellitus-typu-2-sa-maju-stiahnut-z-trhu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/vysledok-procedury-podla-clanku-20-nariadenia-ec-c-726-2f2004 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/cerezyme-imigluceraza-aktualna-informacia-o-dodavkach-lieku-a-odporucanie-pre-liecbu-pacientov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-pozastavenie-registracie-pre-liek-octagam-vo-vsetkych-clenskych-statoch-eu 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/pozastavenie-registracie-liekov-s-obsahom-rosiglitazonu-avandia-c2-ae-avandamet-c2-ae-a-avaglim-c2-ae-v-ramci-krajin-europskej-unie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/vfend-vorikonazol-e2-80-93-mozne-riziko-skvamocelularneho-karcinomu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-pouzitie-fibratov-v-druholiniovej-liecbe 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-o-prehodnocovani-liekov-s-obsahom-fibratov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/tiomersal-vo-vakcinach-pre-humanne-pouzitie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/slavnostne-odovzdavanie-narodnej-ceny-sr-za-kvalitu-2010 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/novela-zakona-c.-331-2005-z.-z.-o-drogovych-prekurzoroch-a-zakona-c.-140-1998-z.-z.-o-liekoch-a-zdravotnickych-pomockach 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/ostatne-pokyny-a-oznamy-pre-ziadatelov-a-drzitelov-rozhodnuti-o-registracii-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/hlasenie-o-neziaducich-ucinkoch/vyznam-hlasenia-neziaducich-ucinkov-liekov 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/nplate-romiplostim-e2-80-93-revizia-upravy-davky-u-pacientov-s-itp-a-upozornenia-pre-pouzivanie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/dianeal-roztok-na-peritonealnu-dialyzu-e2-80-93-stiahnutie-sarze-z-trhu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-vypracovanie-akcneho-planu-tykajuceho-sa-moznej-pritomnosti-endotoxinov-v-roztokoch-na-peritonealnu-dialyzu-od-spolocnosti-baxter 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/akcny-plan-sukl-tykajuci-sa-moznej-pritomnosti-endotoxinov-v-roztokoch-na-peritonealnu-dialyzu-od-spolocnosti-baxter 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/mozne-nahrady-za-dianeal-podla-sukl-roztoky-podobneho-zlozenia-glukoza-kalcium-ph 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/dianeal-nutrineal-roztoky-na-peritonealnu-dialyzu-e2-80-93-stiahnutie-sarzi-z-trhu-a-monitorovanie-pripadov-aseptickej-peritonitidy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/homeopaticka-vakcina 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-ukoncila-prehodnotenie-lieku-avastin-pouzivaneho-na-liecbu-karcinomov-prsnika 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/vakciny/prehlad-vakcin-v-povinnom-ockovani-a-popis-ich-pomocnych-latok 2026-03-20 weekly https://www.sukl.sk/sk/media/spravy-2011/vyjadrenie-statneho-ustavu-pre-kontrolu-lieciv-k-vakcinam-proti-pneumokokovym-infekciam-sukl-minister-zdravotnictva-konal-na-zaklade-odbornych-poziadaviek 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/vyhlaska-ministerstva-hospodarstva-sr-c.-12-2011-z.z 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/podavanie-hlaseni-o-uvadzani-urcenych-latok-na-trh 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/multaq-dronedaron-e2-80-93-informacia-o-tazkom-poskodeni-pecene 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/osteonekroza-celuste-u-pacientov-s-nadorovym-ochorenim-ktori-su-lieceni-sunitinibom-sutent-a-sucasne-uzivaju-alebo-v-minulosti-uzivali-bisfosfonaty 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/vistide-citodovir-e2-80-93-zavazne-neziaduce-ucinky-pri-pouziti-mimo-schvalenu-indikaciu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/prehodnocovanie-vyrobneho-procesu-roztokov-na-peritonealnu-dialyzu-spolocnosti-baxter-ktore-bolo-iniciovane-kvoli-moznemu-vyskytu-endotoxinov-v-niektorych-sarzach 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/prehodnocovanie-pomeru-prinosu-a-rizika-lieku-multaq 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/mozne-riziko-poskodenia-pecene-pri-pouzivani-lieku-multaq-dronedaron- 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/informacia-o-potencialnej-kontaminacii-tamponov-hw-alco-prep-alco-swab-od-vyrobcov-hw-cv-belgicko-b.braun-melsungen-ag-nemecko-a-subdodavatela-triad-group-usa-mikroorganizmom-bacillus-cereus 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2011 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/pegintron-a-intron-a-e2-80-93-kontaminovane-alkoholove-tampony 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/doba-pouzitelnosti-tamiflu-cps-dur 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny/nova-legislativa-europskej-unie-zamerana-na-farmakovigilanciu 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/legislativa/predpisy-a-doporucenia-pic-2fs-v-oblasti-svp 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/lucentis-10-mg-2fml-e2-80-93-chyba-v-kvalite-ihiel 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/lucentis-10-mg-2fml-e2-80-93-chyba-v-kvalite-ihiel- 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/klinicke-skusanie-vakcin 2026-03-20 weekly https://www.sukl.sk/o-nas/zmluvy-za-sukl/zmluvy-uzatvorene-od-1.-januara-2011 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/news/commission-regulation-eu-no-225-2011-of-7-march-2011-amending-commission-regulation-ec-no-1277-2005-drug-precursors 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/scintimun-besilesomab-e2-80-93-potencialny-vznik-protilatok 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/thyrogen-thyrotropin-alfa-e2-80-93-znizenie-dodavok-lieku-na-trh 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/kontrastne-latky-obsahujuce-gadolinium-e2-80-93-nefrogenna-systemova-skleroza 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2010 2013-09-11 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/nadpis 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/nadpis-1 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-zrusit-pozastavenie-registracie-lieku-octagam 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/otazky-a-odpovede-o-zruseni-pozastavenia-registracie-lieku-octagam-ludsky-imunoglobulin-5-a-10- 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/thalidomide-clegene-talidomid-e2-80-93-riziko-trombembolie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/vakciny/nadpis 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zerit-stavudin-obmedzenia-indikacie-lieku 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/revlimid-lenalidomid-e2-80-93-riziko-druhych-primarnych-malignit- 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-kvality/nadpis 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/nadpis-2 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/bezpecnostne-opatrenia-a-upozornenia/nadpis-3 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/pokracujuce-prehodnocovanie-prinosu-a-rizika-liekov-s-obsahom-pioglitazonu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/posobnost/zoznam-inspektorov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-ukoncila-prehodnotenie-systemovo-podavanych-liekov-s-obsahom-lieciva-nimesulidu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-obmedzenie-pouzivania-liekov-s-obsahom-dexrazoxanu 2026-03-20 weekly https://www.sukl.sk/o-nas/verejne-obstaravanie/suhrnne-spravy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-potvrdila-pozitivny-pomer-prinosu-a-rizik-pre-liek-champix 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cardioxane-dexrazoxan-kontraindikovanie-u-deti-a-mladistvych 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacia-o-prebiehajucom-posudeni-prinosov-a-rizik-lieku-multaq-europskou-liekovou-agenturou 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-nove-kontraindikacie-a-upozornenia-pre-pioglitazon-s-cielom-redukovat-mierne-zvysene-riziko-rakoviny-mocoveho-mechura 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/multaq-dronedaron-predbezne-udaje-z-klinickej-studie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pioglitazon-male-zvysenie-rizika-karcinomu-mocoveho-mechura 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov 2026-03-31 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/sprycel-dasatinib-suvislost-s-plucnou-arterialnou-hypertenziou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mabthera-rituximab-fatalne-reakcie-suvisiace-s-infuziou-u-pacientov-s-reumatoidnou-artritidou 2026-03-20 weekly https://www.sukl.sk/sk/posudzovanie-kvality-liekov/liekopis/mp-128-2011-ziadost-o-reviziu-monografie-alebo-vseobecneho-clanku-europskeho-liekopisu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2009 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/nplate-romiplastim-riziko-progresie-do-akutnej-myeloidnej-leukemie-u-pacientov-s-myelodysplastickym-syndromom 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/nedostatok-lieku-apidra-inzulin-glulizin-vo-forme-naplni 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-k-prehodnoteniu-lieku-multaq-dronedaron 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-obmedzit-pouzivanie-lieku-multaq 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-prehodnocuje-lieky-s-obsahom-orlistatu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-usudila-ze-pomer-prinosu-a-rizika-lieku-revlimid-je-aj-nadalej-pozitivny 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-tykajuce-sa-prehodnotenia-revlimidu-lenalidomid 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/sukl-oznamuje-ze-drzitel-registracie-sanofi-aventis-pharma-slovakia-s.r.o.-v-suvislosti-s-nedostatkom-lieku-apidra-v-sucasnosti-distribuuje-listy-zdravotnickym-pracovnikom-lekarom-pacientom-a-obchodnym-partnerom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/revatiosildenafil-zvysene-riziko-pri-vysokych-davkach-u-deti-s-plucnou-arteriovou-hypertenziou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vfend-vorikonazol-chyba-v-opise-upravy-davkovania-v-pisomenej-informacii-pre-pouzivatelov 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/withdrawal-of-the-marketing-authorization-only-for-the-certain-strength-of-the-product 2026-03-20 weekly https://www.sukl.sk/sk/klinick-skanie-liekov/databza-klinickho-skania/databaza-klinickeho-skusania-liekov-v-europskej-unii 2026-03-20 weekly https://www.sukl.sk/sk/klinick-skanie-liekov/databza-klinickho-skania/databaza-pediatrickych-klinickych-skusani-v-eu 2026-03-20 weekly https://www.sukl.sk/sk/klinick-skanie-liekov/databza-klinickho-skania/narodna-databaza-intervencnych-klinickych-skusani 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/spristupnenie-databazy-klinickeho-skusania-v-slovenskej-republike 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/revlimid-lenalidomid-riziko-druhych-primarnych-malignit 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-spristupnil-na-svojich-strankach-moznost-vyhladavania-tzv.-orphan-liekov 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-pre-nemocnice-zdravotnickych-pracovnikov-a-poskytovatelov-zdravotnej-starostlivosti-o-povinnosti-hlasit-nehody-poruchy-a-zlyhania-zdravotnickych-pomocok-statnemu-ustavu-pre-kontrolu-lieciv 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/multaq-dronedaron-informacia-o-obmedzeni-pouzivania-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/urorec-a-siloxyl-silodisin-spojenie-s-peroperacnym-syndromom-plavajucej-duhovky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/xigris-aktivovany-alfadrotrekogin-bude-stiahnuty-z-trhu-z-dovodu-nedostatocnej-ucinnosti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/stiahnutie-lieku-xigris-aktivovany-alfadrotrekogin-z-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pradaxa-dabigatranetexilat-dolezitost-sledovania-oblickovych-funkcii 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/instructions/main-changes-in-slovak-drug-law-clinical-trials-human 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/duration-of-approval-process/duration-of-approval-process-2010 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/domperidon-kardiovaskularne-riziko 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/prostin-15-m-carboprostum-trometanoli-hlasenia-o-nespravnom-sposobe-podania-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/caelyxr-pegylovany-lipozomalny-doxorubicin-informacia-o-zasobovani-a-bezpecnosti-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vectixib-dolezitosti-urcovania-stavu-genu-kras-pred-liecbou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/suvislost-lieku-seropram-citalopram-s-predlzenim-qt-intervalu-v-zavislosti-od-davky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/spracovanie-ziadosti-ectd-v-slovenskej-republike 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/market-access-pacientske-registre-a-market-access-zdravotnicke-pomocky-a-dieteticke-potraviny 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/torisel-semsirolimus-koncetrat-a-rozpustadlo-na-infuzny-roztok-potreba-vizualneho-skontrolovania-prilozeneho-rozpustadla 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/taxocere-docetaxel-infuzny-koncetrat-riziko-vytlacenia-drobnych-castic-zatky-pri-pouziti-hrubsich-injekcnych-ihiel 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/peyona-kefeincitrat-informacia-o-bezpecnom-pouzivani-lieku 2026-03-20 weekly https://www.sukl.sk/o-nas/verejne-obstaravanie/zverejnenie-zmluv-v-zmysle-uznesenia-vlady-sr-c.-603-2010 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-ema-zacala-prehodnotenie-liekov-obsahujucich-aliskiren 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/aktualna-informacia-tykajuca-sa-prsnikovych-implantatov-pip 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/dotazniky/dotaznik-spokojnosti-zakaznika 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/medzinarodne-harmonizovane-poziadavky-na-analyticky-certifikat 2026-04-15 weekly https://www.sukl.sk/sk/inspekcia/spravna-prax-pripravy/zoznam-vydanych-osvedceni-o-dodrziavani-zasad-spptl 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-zacala-prehodnocovanie-lieku-gilenya-fingolimod-registrovaneho-na-liecbu-roztrusenej-sklerozy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-o-prebiehajucom-prehodnocovani-lieku-gilenya-fingolimod 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/aktualna-informacia-tykajuca-sa-prsnikovych-implantatov-pip-v-suvislosti-so-stanoviskom-scenihr-ku-dnu-2.2.2012 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2012 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy 2026-03-12 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-navstivili-studenti-z-ruska 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/aktualna-sprava-ohladom-bedrovych-endoprotez-od-spolocnosti-depuy-international 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/strattera-atomoxetin-rizika-zvyseneho-krvneho-tlaku-a-srdcovej-frekvencie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/rasilez-aliskiren-riziko-kardiovaskularnych-a-renalnych-komplikacii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/velcade-bortezomib-spravna-cesta-podania-je-intravenozne-podanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gilenya-fingolimod-potreba-intenzivneho-sledovania-kardiovaskularneho-systemu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pioglitazon-mierne-zvysenie-rizika-karcinomu-mocoveho-mechura 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/verejne-obstaravanie/prehlad-dodavatelskych-faktur 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/aulin-nimed-nimesulid-zrusenie-indikacie-symptomaticka-liecba-bolestivej-osteoartrozy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/postregistracna-kontrola-kvality/hlasenie-dovozu-neregistrovanych-liekov-na-zaklade-povolenia-mz-sr 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/obmedzenie-pouzivania-liekov-s-obsahom-nimesulidu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/verejne-obstaravanie/prehlad-objednavok 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/nimesil-nimesulid-zrusenie-indikacie-symptomaticka-liecba-bolestivej-osteoartrozy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-vydala-odporucanie-pre-12-centralne-registrovanych-liekov-vyrabanych-v-ben-venue-laboratories 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-upozornuje-na-nove-kontraindikacie-liekov-s-obsahom-aliskirenu 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/instructions/adverse-event-reaction-in-a-clinical-trial-reporting-requirements-in-the-slovak-republic 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/falzifikaty-lieku-avastin-sa-na-slovensku-nenachadzaju 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/29.-februar-je-dnom-zriedkavych-chorob 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky-informacie/informacie-tykajuce-sa-registracie-oznamenia-zp/zdravotnicke-pomocky-triedy-i-informacie-pre-vyrobcov-so-sidlom-v-sr 2021-11-02 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tienovi-ministri-vystupili-s-viziami-slovenskeho-zdravotnictva 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/postregistracna-kontrola-kvality/hlasenie-distributora-do-7-dni-po-dovoze 2026-03-20 weekly https://www.sukl.sk/sk/inpekcia/legislatva/zkon-.-362-2011-z.z.-o-liekoch-a-zdravotnckych-pomckach-a-o-zmene-a-doplnen-niektorch-zkonov 2026-03-20 weekly https://www.sukl.sk/sk/inpekcia/legislatva/zkon-.-331-2005-z.-z.-v-znen-neskorch-predpisov 2026-03-20 weekly https://www.sukl.sk/sk/klinick-skanie-liekov/databza-klinickho-skania/register-neintervencneho-klinickeho-skusania-v-eu 2026-03-20 weekly https://www.sukl.sk/sk/klinick-skanie-liekov/databza-klinickho-skania/neintervencne-klinicke-skusanie-v-slovenskej-republike 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/oznam-pre-pacientov-s-asr-implantatmi 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/pokyny/predlozenie-informacii-o-liekoch-registrovanych-v-eu-v-elektronickej-forme-vyzva-pre-drzitelov-rozhodnuti-o-registracii-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/carboplatin-bezpecne-podavanie-10mg-ml-infuzneho-koncentratu 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2011 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/protelos-a-osseor-stroncium-ranelat-nove-kontraindikacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/perfalgan-paracetamol-intravenozny-riziko-nahodneho-predavkovania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/onglyza-saxagliptin-zavazne-hypersenzitivne-reakcie-a-pankreatitida 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/brinavess-vernakalant-potreba-monitorovania-krvneho-tlaku-a-srdcpvej-frekvencie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/informacie-tykajuce-sa-antikoncepcnych-liekov-yaz-yadine-yasmin-a-yasminelle 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/gilenya-fingolimod-potreba-sledovania-kardiovaskularneho-systemu-aktualizacia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/benlysta-belimumab-reakcie-z-precitlivenosti-a-reakcie-na-infuziu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/vyhlaska-mz-sr-c.-128-2012-o-poziadavkach-na-spravnu-vyrobnu-prax-a-poziadavkach-na-spravnu-velkodistribucnu-prax 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-vydala-nove-odporucania-tykajuce-sa-uzivania-lieku-gilenya 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/vyhlaska-mz-sr-129-2012-o-poziadavkach-na-spravnu-lekarensku-prax 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/hypertenziou-trpi-kazdy-stvrty-slovak 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-sukl-k-vyjadreniu-oz-slovensky-pacient 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zavislost-od-nikotinu-skracuje-fajciarom-zivot-az-o-8-rokov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/spotreba-liekov-na-slovensku-v-roku-2011-kopirovala-trend-predoslych-rokov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/protopic-takrolimus-odporucania-na-spravne-pouzitie-pre-minimalizaciu-rizika 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-potvrdila-pozitivny-prinos-lieku-pradaxa-ziada-ale-spresnenie-informacii-pre-lekarov-a-pacientov-spc-a-pil 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/pri-analyze-latky-succinylsulfathiazol-dosiahol-statny-ustav-vyborne-vysledky 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/oddelenie-spravnej-vyrobnej-a-velkodistribucnej-praxe/ziadost-o-inspekciu-vydanie-posudku-sukl 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/oddelenie-spravnej-vyrobnej-a-velkodistribucnej-praxe/drzitelia-osvedcenia-svp-a-api-registracie 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/oddelenie-spravnej-vyrobnej-a-velkodistribucnej-praxe/postup-pre-vydavanie-certifikatu-pre-produkt-cpp-podla-schemy-szo 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-zverejnuje-hlasene-podozrenia-na-neziaduce-ucinky-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/hlasenie-podozreni-na-neziaduce-ucinky-liekov/databanka-neziaducich-ucinkov-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/spracovanie-ludskej-krvi-podlieha-prisnej-kontrole 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-obmedzenie-indikacii-liekov-s-obsahom-trimetazidinu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-odporuca-obmedzenie-indikacii-liekov-s-obsahom-tolperizonu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/informacie-ohladom-pravidelnych-aktualizacii-referencnych-nazvov-liekovych-foriem 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mircera-metoxypolyetylen-glykol-epoetin-beta-odporucania-alternativnej-liecby-pri-nedostatku-lieku-na-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/riaditel-sukl-privital-kolegov-z-cinskej-liekovej-agentury 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/farmakoekonomika-z-pohladu-odbornikov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/upozornenie-na-internetovy-predaj-neregistrovanych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/kontrolne-laboratorium-bratislava-oslavuje-60-rokov-svojej-existencie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-neodporuca-dlhodobe-uzivanie-liekov-s-obsahom-kalcitoninu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/postregistracna-kontrola-kvality/stvrtrocne-hlasenie-distributora-o-mnozstve-a-druhu-distribuovanych-a-vyvezenych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/pokyny/formular-pre-hlasenie-pripravovanej-reklamy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vectibix-panitumumab-zavazne-zivot-ohrozujuce-kozne-reakcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/volibris-ambrisentan-kontraindikacia-pre-pacientov-s-idiopatickou-plucnou-fibrozou 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/qrd-templaty 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zofran-ondansetron-nove-obmedzenie-pre-i.v.-pouzitie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mabcampath-alemtuzumab-ukoncenie-dostupnosti-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/aktualizacia-informacie-ohladom-zrusenia-registracie-lieku-mabcampath-alemtuzumab 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stretnutie-ceskych-a-slovenskych-kolegov-bolo-venovane-problematike-ectd 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/pokyny/definicie-zakladnych-pojmov-farmakovigilancie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pendepon-compositum-benzathini-benzylpenicillinum-procaini-benzylpenicillinum-docasny-vypadok-lieku-z-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/seroquel-xr-quetiapini-fumaras-ovplyvnenie-metabolickych-parametrov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/studie-bezpecnosti-lieku 2018-07-23 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/studie-bezpecnosti-lieku/europska-databanka-pass 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/studie-bezpecnosti-lieku/pokyny 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/studie-bezpecnosti-lieku/pokyny/pokyny-pre-pripravu-a-vykonavanie-studii-bezpecnosti-lieku-po-registracii 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/studie-bezpecnosti-lieku/zaverecne-spravy-studii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/inspektori-z-ciech-a-slovenska-na-stretnuti-na-morave 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/upozornenie-pre-obcanov-tykajuce-sa-chybneho-oznacenia-na-vonkajsom-obale-zdravotnickej-pomocky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/depocyte-lipozomalny-cytarabin-problem-zabezpecenia-sterility-pri-vyrobe-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xgeva-denosumab-riziko-hypokalciemie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/kalcitoniny-zvysene-riziko-nadorovych-ochoreni-a-stiahnutie-nososvej-aerodisperzie-z-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/choroba-zabudania-postihuje-najma-ludi-po-65-ke 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/nezelanemu-tehotenstvu-sa-da-zabranit-viacerymi-antikoncepcnymi-pripravkami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/preductal-mr-trimetazidin-obmedzenie-indikacii-na-pridavnu-symptomaticku-liecbu-stabilnej-anginy-pektoris 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/macugen-pegabtanib-sodny-riziko-podstatneho-zvysenia-vnutroocneho-tlaku-pri-vnutroocnom-vpichnuti-nadbytocneho-objemu-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/typhim-vi-vakcina-proti-brusnemu-tyfusu-dobrovolne-stiahnutie-niekolkych-sarzi-vakciny 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vascotazin-35-mg-trimetazidin-obmedzenie-indikacii-na-pridavnu-symptomaticku-liecbu-stabilnej-anginy-pektoris 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/statny-ustav-nariadil-stiahnutie-jednej-sarze-vakciny-infanrix-hexa-pacienti-ohrozeni-nie-su 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-nariadil-stiahnutie-jednej-sarze-vakciny-infanrix-hexa-pacienti-ohrozeni-nie-su 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/stiahnutie-z-trhu-infanrix-hexa-sarza-a21cb191b 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/vakciny/zabezpecenie-kvality-vakcin 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-o-prehodnocovani-liekov-s-obsahom-tolperizonu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-ukoncila-prehodnocovanie-udajov-o-kardiovaskularnej-bezpecnosti-nesteroidovych-protizapalovych-liekov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacie-pre-pacientov-a-zdravotnickych-pracovnikov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/apstar-35-mg-trimetazidin-obmedzenie-indikacii-na-pridavnu-symptomaticku-liecbu-stabilnej-anginy-pektoris 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/protevasc-35-mg-trimetazidin-obmedzenie-indikacii-na-pridavnu-symptomaticku-liecbu-stabilnej-anginy-pektoris 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-36-2012 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/caelyx-pegylovany-lipozomalny-doxorubicin-opatovne-zavedenie-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/neliecena-cukrovka-moze-sposobit-vazne-problemy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/buduci-farmaceuticki-laboranti-navstivili-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/trimetazidin-ratiopharm-20-mg-trimetazidin-obmedzenie-indikacii-na-pridavnu-symptomaticku-liecbu-stabilnej-anginy-pektoris 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/trimetazidin-dg-pr-35-mg-trimetazidin-obmedzenie-indikacii-na-pridavnu-symptomaticku-liecbu-stabilnej-anginy-pektoris 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/paracetamol-b.braun-10-mg-ml-paracetamol-rizika-nahodneho-predavkovania-u-novorodencov-dojciat-a-dospelych-s-podvahou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/za-okruhlym-stolom-sa-diskutovalo-o-klinickych-studiach-a-inovativnych-liekoch 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/upozornenie-na-predaj-neregistrovanych-liekov-cez-internet 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tyverb-lapatinib-v-niektorych-pripadoch-menej-ucinny-ako-rezimy-zalozene-na-herceptine-trastuzumab 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/elontril-wellbutrin-sr-buproprion-mozne-zvysene-riziko-niektorych-kongenitalnych-kardiovaskularnych-malformacii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/faq 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/posobnost 2016-06-23 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-zacina-prehodnocovanie-lieku-tredaptive 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/legislativa/zakon-c.-362-2011-z.-z.-o-liekoch-a-zdravotnickych-pomockach-a-o-zmene-a-doplneni-niektorych-zakonov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/legislativa/zakon-c.-147-2001-z.-z.-o-reklame-a-o-zmene-a-doplneni-niektorych-zakonov-v-zneni-neskorsich-predpisov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/legislativa/zakon-c.-308-2000-z.-z.-o-vysielani-a-retransmisii-a-o-zmene-a-zakona-c.-195-2000-z.-z.-o-telekomunikaciach-v-zneni-neskorsich-predpisov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/legislativa/zakon-c.-71-1967-zb.-o-spravnom-konani-spravny-poriadok-v-zneni-neskorsich-predpisov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/tredaptive-kyselina-nikotinova-laropiprant-odporucanie-nezacinat-liecbu-u-novych-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pradaxa-dabigatranetoxilat-kontraindikacia-u-pacientov-s-umelymi-nahradami-srdcovych-chlopni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualne-informacie-tykajuce-sa-liekov-s-obsahom-mifepristonu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gilenya-fingolimod-spresnenie-pokynov-na-sledovanie-po-podani-prvej-davky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-potvrdila-odporucania-na-pozastavenie-uzivania-lieku-tredaptive 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tredaptive-kyselina-nikotinova-laropiprant-liecba-liekom-sa-ma-ukoncit 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2013 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/studenti-farmacie-z-yekaterinburgu-po-roku-opat-na-navsteve-v-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualne-informacie-o-liekoch-s-obsahom-cyproteronacetatu-a-etinylestradiolu-diane-35-a-generika 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/reakcia-sukl-na-stanovisko-anny-zaborskej-k-lieku-diane-35 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-zacina-prehodnocovat-uzivanie-lieku-diane-35 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mydocalm-tolperizon-obmedzenie-indikacii-zrusenie-parenteralnej-formy-riziko-alergickych-reakcii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/prolia-denosumab-riziko-atypickych-fraktur 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/vakciny/prirodzene-reakcie-organizmu-na-ockovanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-liecbe-zriedkavych-ochoreni-pomahaju-tzv.-orphan-lieky 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-sukl-a-mz-sr-2016 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/hlasenie-podozreni-na-neziaduce-ucinky-liekov/cierny-trojuholnik 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-zacala-prehodnocovanie-liekov-s-obsahom-domperidonu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-37-2013 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/neuroblock-botulotoxin-typu-b-riziko-pri-pouzivani-mimo-schvalenej-indikacii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mimpara-cinakalcet-hlasenie-fatalneho-pripadu-so-zavaznou-hypokalciemiou-v-pediatrickej-studii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/nulojixe-belatacept-riziko-rejekcie-stepu-pri-znizeni-davky-kortikosteroidov-u-pacientov-s-vysokym-imunologickym-rizikom-rejekcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/incivo-telaprenavir-zvladnutie-zavaznych-koznych-reakcii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/rotateq-ockovacia-latka-proti-rotavirusom-aktualizacia-pribalovej-informacie-pre-pouzivatela 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/predkladanie-asmf-na-sukl 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-38-2013 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/odporucanie-na-pozastavenie-registracie-liekov-s-obsahom-tetrazepamu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/odporucanie-na-obmedzenie-pouzivania-lieku-protelos 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/increlex-10-mg-ml-mekasermin-docasne-prerusenie-dodavok-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/informacie-ohladom-nedostupnosti-lieku-increlex-mekasermin 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2012 2013-05-03 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/cinnost-statneho-ustavu-v-roku-2012 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mabthera-rituximab-suvislost-so-zavaznymi-koznymi-reakciami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/thalidomide-celgene-talidomid-riziko-druhych-primarnych-malignit 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/liek-diane-35-ostava-v-terapeutickej-praxi-len-pre-urcene-pacientky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-nepovolil-vyvoz-lieku-lyrica 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualne-informacie-tykajuce-sa-stiahnutia-lieku-cilest-norgestimat-a-etinylestradiol 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fragmin-aktualizacia-pisomnej-informacie-pre-pouzivatela 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/avastin-bevacizumab-pripady-nekrotizujucej-fasciitidy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/protelos-osseor-stroncium-ranelat-dolezite-obmedzenia-pre-pouzitie-pre-riziko-infarktu-myokardu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/pozastavenie-registracie-lieku-myolastan-tetrazepam 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cilest-etinylestradiol-gestimat-nedostatok-lieku-na-trhu-z-dovodu-jeho-stahnutia-pre-chybu-v-kvalite 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vreya-a-chloe-etinylestradiol-cyproteronacetat-zmena-indikacie-nove-kontraindikacie-a-upozornenia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/diane-35-a-minerva-etinylestradiol-cyproteronacetat-zmena-indikacie-nove-kontraindikacie-a-upozornenia 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/odporucenie-na-obmedzenie-pouzivania-liekov-s-obsahom-diklofenaku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/trobalt-retigabin-liecba-moze-viest-k-pigmentovym-zmenam-ocnych-tkaniv-koze-pier-alebo-nechtov 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky-informacie/zdravotnicke-pomocky-na-mieru-a-aktivne-implantovatelne-zdravotnicke-pomocky-na-mieru-informacie-pre-vyrobcov-so-sidlom-v-sr 2024-09-27 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-s-obsahom-flupirtinu-nove-obmedzenia-na-pouzitie-suvisiace-s-hepatotoxicitou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/distribucia/subezny-dovoz 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/prehodnocovanie-pouzivania-infuznych-roztokov-s-obsahom-hydroxyetylskrobu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/obmedzenie-pouzivania-kodeinu-u-deti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/depocyte-sus-inj-1.5-ml-50-mg-lipozomalny-cytarabin-obnovenie-dodavok-na-europsky-trh 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-s-obsahom-dihydroergotoxinu-obmedzenie-indikacii-v-suvislosti-s-rizikom-fibrozy-a-ergotizmu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/votrient-pazopanib-dolezita-zmena-frekvencie-kontrolovania-pecenovych-testov-kvoli-hepatotoxicite 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-nepovolil-vyvoz-liekov-inspra-25-mg-clexane-2000-a-azilect 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-odporucila-pozastavenie-registracie-pre-lieky-s-obsahom-ketokonazolu-ktore-sa-uzivaju-peroralne 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/roferon-a-interferon-alfa-2a-ocakavany-vypadok-lieku-na-trhu 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/oddelenie-spravnej-vyrobnej-a-velkodistribucnej-praxe/oznamenie-o-zamere-vykonavat-vyrobu-dovoz-alebo-distribuciu-ucinnej-latky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/imnovid-pomalidomid-program-prevencie-gravidity 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vectibix-panitumumab-dolezitost-stanovenia-stavu-genu-ras-divokeho-typu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zofran-ondansetron-najnovsia-informacia-o-davkovani-pri-intravenoznom-podani 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/distribucia/sprostredkovanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/internetovy-vydaj-liekov-a-zdravotnickych-pomocok 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/tradicne-rastlinne-lieky/poziadavky-na-registraciu-tradicnych-rastlinnych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/nizoral-ketokonazol-200-mg-tablety-pozastavenie-registracie-v-europskej-unii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/neupogen-filgrastim-neulasta-pegfilgastrim-riziko-kapilarneho-presakovania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lariam-meflochin-riziko-neuropsychiatrickych-reakcii 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/otazky-a-odpovede-k-stiahnutiu-lieku-paralen-grip-chripka-a-bolest 2026-03-20 weekly https://www.sukl.sk/o-nas/verejne-obstaravanie/profil-verejneho-obstaravatela 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stretnutie-s-novinarmi-bolo-venovane-teme-reexportu 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/memorandum-o-spolupraci-s-farmaceutickou-fakultou-univerzity-komenskeho-v-bratislave 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/novomix-30-flexpen-oznamy-drzitela-registracie-pre-odbornu-verejnost-a-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-nariadil-stiahnutie-dvoch-sarzi-lieku-novomix-30-flexpen-z-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/valdoxan-agomelatin-vyznam-sledovania-funkcie-pecene-a-nova-kontraindikacia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/risperidon-a-paliperidon-riziko-peroperacneho-syndromu-vlajucej-duhovky-u-pacientov-podstupujucich-operaciu-katarakty 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/diklofenak-nove-kontraindikacie-a-upozornenia 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-39-2013 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-s-obsahom-hydroxyetyl-skrobu-obmedzenie-indikacii-a-nove-kontraindikacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/numeta-g16e-mozne-riziko-vzniku-hypermagneziemie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/jevtana-potencialna-medikacna-chyba-pri-priprave-infuzneho-roztoku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mabthera-rituximab-skrining-hepatitidy-pred-zacatim-liecby 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/riziko-zavaznej-alergickej-reakcie-pri-intravenozne-podavanych-liekoch-s-obsahom-zeleza 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lutinus-zmena-farby-blistra-a-tabliet-u-sarze-c.-0804.207a-1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gileya-fingolimod-hemofagocytovy-syndrom 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-ukoncila-prehodnocovanie-bezpecnosti-kombinovanej-hormonalnej-antikoncepcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/carbomedac-10-mg-ml-infuzny-koncentrat-karboplatina-moznost-tvorby-krystalickych-castic 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/temozolomid-potreba-vysetrovania-pecene-pre-moznu-zavaznu-hepatalnu-toxicitu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-nepovolil-vyvoz-dalsich-17-liekov 2026-03-20 weekly https://www.sukl.sk/o-nas/zmluvy-za-sukl/centralny-register-zmluv 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/oznam-o-plateni-spravnych-poplatkov-rozhodnutia-sukl-vo-veci-drogovych-prekurzorov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/erbitux-cetuximab-dolezitost-zistovania-divokeho-typu-genov-ras-pred-liecbou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/anavenol-ukoncenie-vyroby-a-distribucie-zrusenie-registracie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/arzerra-ofatumumab-skrining-hepatitidy-b-u-vsetkych-pacientov-pred-liecbou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/efient-prasugrel-zvysene-riziko-krvacania-pri-podani-pred-diagnostickou-koronarnou-angiografiou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/increlex-mekasermin-obnovenie-dodavok-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/metoclopramid-aktualizacia-indikacii-a-zmeny-davkovania-za-ucelom-znizenia-neziaducich-ucinkov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/abraxane-paklitaxel-vo-forme-nanacastic-viditelne-vlanka-v-intravenoznom-infuznom-vaku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/kombinovana-hak-posudenie-rizika-tromboembolie-medzi-jednotliymi-liekmi 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-40-2014 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-odporuca-prijatie-dalsich-obmedzeni-pri-pouzivani-lieku-protelos 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/periolimel-olimel-parenteralna-vyziva-znizenie-maximalnej-rychlosti-podavania-infuzie-u-deti-od-2-do-11-rokov 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/news/no-331-act-of-23-june-2005-on-state-administration-authorities-in-matters-of-drug-precursors-and-on-amendments-and-additions-to-some-laws 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/news/regulation-eu-no-1258-2013-of-the-european-parliament-and-of-the-council-of-20-november-2013-amending-regulation-ec-no-273-2004-on-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/news/regulation-eu-no-1259-2013-of-the-european-parliament-and-of-the-council-of-20-november-2013-amending-council-regulation-ec-no-111-2005-laying-down-rules-for-the-monitoring-of-trade-between-the-community-and-third-countries-in-drug-precursors 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/protelos-osseor-stroncium-ralenat-nove-obmedzenie-v-indikacii-a-odporucania-na-monitorovanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/stanovisko-k-obmedzeniu-pouzivania-kyseliny-boritej-a-jej-soli-v-individualnej-priprave-liekov-v-lekarnach 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/obmedzenie-pouzivania-liekov-s-obsahom-diacereinu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/postregistracna-kontrola-kvality/vyvoz-humanneho-lieku 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2014 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/falzifikat-lieku-oznaceny-ako-pegasysr-pegylovany-interferon-alfa-2a-naplnena-injekcna-striekacka-180-mcg-05-ml 2014-04-24 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/informacie-o-vyskyte-falzifikatov-lieku-herceptin-v-niektorych-krajinach-eu 2022-04-05 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2013 2014-04-24 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/cinnost-statneho-ustavu-v-roku-2013 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/odklad-vykonatelnosti-napadnuteho-rozhodnutia-c.j.-3430-2012-600 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/nove-odporucania-pri-uzivani-liekov-s-obsahom-zolpidemu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/obmedzenie-pouzivania-liekov-s-obsahom-domperidonu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/procoralan-corlentor-ivabradin-predchadzanie-potencialne-nebezpecnej-bradykardie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/lieky-ponukane-nezakonne-cez-internet-nesplnaju-pozadovane-parametre 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/podpredsednicka-senatu-cr-navstivila-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/informacie-pre-lekarnikov-v-suvislosti-s-vydajom-nudzovej-antikoncepcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/simulect-basilixumab-pouzivanie-iba-v-schvalenych-indikaciach 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/interferony-beta-riziko-trombotickej-mikroangiopatie-a-nefrotickeho-syndromu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xgeva-denosumab-minimalizacia-rizika-osteonekrozy-celuste-a-hypokalciemie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/prolia-denosumab-minimalizacia-rizika-osteonekrozy-celuste-a-hypokalciemie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/informacie-k-pozastaveniu-pouzivania-jednej-sarze-vakciny-infanrix-hexa-v-cr 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/sukl-vypracoval-prvu-cast-2.-vydania-slovenskeho-farmaceutickeho-kodexu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/sonovue-siran-hexafluoridu-upravene-kontraindikacie-varovania-a-opatrenia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/aceklofenak-nove-kontraindikacie-a-upozornenia 2026-03-20 weekly https://www.sukl.sk/sk/o-nas/legislativa/pravne-predpisy-eu 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vectibix-panitumumab-upozornenie-na-chybny-preklad-v-suhrne-charakteristickych-vlastnosti-lieku 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/hlasenie-podozreni-na-neziaduce-ucinky-liekov/vedeli-ste-ze-mozete-sami-nahlasit-vedlajsie-ucinky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-41-2014 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-42-2014 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/eligard-leukoprelinacetat-riziko-nedostatocnej-ucinnosti-pri-nespravnom-postupe-jeho-rekonstitucie-a-pri-nespravnom-pouziti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tecfidera-dimetylfumarat-progresivna-leukoencefalopatia-u-pacienta-s-tazkou-dlhotrvajucou-lymfopeniou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/procoralan-corlentor-ivabradin-hydrochlorid-nova-kontraindikacia-a-odporucanie-na-minimalizaciu-rizika-kardiovaskularnych-prihod-a-zavaznej-bradykardie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cellcept-mykofenolat-mofetil-nove-upozornenie-na-riziko-hypogamaglobulinemie-a-bronchiektazie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-obsahujuce-valproat-riziko-vzniku-vrodenych-malformacii-a-vyvojovych-problemov-u-deti-ktorych-matky-uzivali-valproat-pocas-tehotenstva 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/inomax-oxid-dusnaty-chybny-ventil-v-niektorych-flasiach-moze-predcasne-zastavit-podavanie-plynu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-sukl-k-odporucaniu-ema-pozastavit-registracie-viacerych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vyhlasenie-spolocnosti-glenmark-pharmaceuticals-s.r.o.-drzitela-rozhodnutia-o-registracii-lieku-apstar-35-mg-tablety-s-predlzenym-uvolnovanim 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy 2020-12-09 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/tradicne-rastlinne-lieky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/homeopatika 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/predlzenie-platnosti-registracie-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/zmena-v-rozhodnuti-o-registracii-lieku 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/registracia-lieku/sukl-ako-referencny-clensky-stat 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-eu-je-registrovanych-83-orphan-liekov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/aktualizacia-informacii-o-liekoch-s-obsahom-ambroxolu-a-bromhexinu-v-suvislosti-s-rizikom-alergie-a-koznych-reakcii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/zakladne-informacie-pre-elektronicke-podavanie-ziadosti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/povinnost-ectd-formatu-registracnej-dokumentacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/technicke-chyby-v-predlozenej-ectd-dokumentacii 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/podavanie-ziadosti-o-nezaradene-zmeny-z-v-registracii-liekov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/pozastavenie-registracie-lieku 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/postregistracne-procesy/sunset-clause 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/vedecke-odporucanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/informacie-o-zmene-sposobu-vydaja-lieku-stopex-na-suchy-kasel-tbl-30x30-mg-a-stopex-junior-15-mg-tablety-tbl-30x15-mg 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2015 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/atarax-hydroxyzin-nove-obmedzenie-pre-dalsiu-minimalizaciu-znameho-rizika-predlzenia-qt-intervalu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/cinnost-statneho-ustavu-v-roku-2014 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2014 2015-04-28 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/imnovid-pomalidomid-nove-rady-pre-minimalizaciu-rizika-hepatotoxicity-intersticialnej-choroby-pluc-a-srdcoveho-zlyhania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gilenya-fingolimod-prvy-pripad-progresivnej-multifokalnej-leukoencefalopatie-u-pacienta-so-sclerosis-multiplex 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/harvoni-sofosbuvirledipasvir-a-kombinacia-daklinza-daklatasvir-plus-sovaldi-sofosbuvir-riziko-klinicky-vyznamnych-arytmii-pri-subeznom-podavani-s-amiodaronom 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-43-2015 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa 2016-07-25 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/regulation-eu-no-1259-2013-of-the-european-parliament-and-of-the-council-of-20-november-2013-amending-council-regulation-ec-no-111-2005-laying-down-rules-for-the-monitoring-of-trade-between-the-community-and-third-countries-in-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/regulation-eu-no-1258-2013-of-the-european-parliament-and-of-the-council-of-20-november-2013-amending-regulation-ec-no-273-2004-on-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/no-331-act-of-23-june-2005-on-state-administration-authorities-in-matters-of-drug-precursors-and-on-amendments-and-additions-to-some-laws 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/commission-regulation-eu-no-225-2011-of-7-march-2011-amending-commission-regulation-ec-no-1277-2005-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/commission-regulation-ec-no-297-2009-amending-regulation-ec-no-1277-2005 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/commission-regulation-ec-no-1277-2005-of-27-july-2005-laying-down-implementing-rules-for-regulation-ec-no-273-2004-of-the-european-parliament-and-of-the-council-on-drug-precursors 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/key-performace-indicators-in-2010 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/key-performace-indicators-in-2011 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/key-performace-indicators-in-2012 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/key-performace-indicators-in-2013 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/key-performace-indicators-in-2014 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/delegovane-nariadenie-komisie-eu-2015-1011-z-24.-aprila-2015-ktorym-sa-doplna-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-drogove-prekurzory 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/vykonavacie-nariadenie-komisie-eu-2015-1013-z-25.-juna-2015-ktorym-sa-stanovuju-pravidla-vzhladom-na-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-drogove-prekurzory 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/commission-delegated-regulation-eu-2015-1011-of-24-april-2015-supplementing-regulation-ec-no-273-2004-of-the-european-parliament-and-of-the-council-on-drug-precursors-and-council-regulation-ec-no-111-2005-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/commission-implementing-regulation-eu-2015-1013-of-25-june-2015-laying-down-rules-in-respect-of-regulation-ec-no-273-2004-of-the-european-parliament-and-of-the-council-on-drug-precursors-and-of-council-regulation-ec-no-111-2005-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/regulation-ec-no-273-2004-of-the-european-parliament-and-of-the-council-of-11-february-2004-on-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/council-regulation-ec-no-111-2005-of-22-december-2004-laying-down-rules-for-the-monitoring-of-trade-between-the-m1-union-and-third-countries-in-drug-precursors 2026-03-20 weekly https://www.sukl.sk/en/inspection/drug-manufacture/list-of-drug-manufacturers 2026-03-20 weekly https://www.sukl.sk/en/inspection/distribution/list-of-issued-certificates-of-compliance-with-the-principles-of-gdp 2026-03-20 weekly https://www.sukl.sk/en/inspection/transfusiology/list-of-issued-certificates-of-good-preparation-practice-for-blood-products 2026-03-20 weekly https://www.sukl.sk/en/inspection/instructions/list-of-inspectors 2026-03-20 weekly https://www.sukl.sk/en/inspection/pharmacy/list-of-pharmacies 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/kineret-100-mg-a-100-mg-067-ml-inj.-roztok-anakinra-reklamacie-lieku-tykajuce-sa-vyskytu-pevnej-hmoty-viditelnej-na-povrchu-ihly 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/invokana-vokanemet-forxiga-xigduo-jardiance-inhibitory-sglt2-riziko-diabetickej-ketoacidozy 2026-03-20 weekly https://www.sukl.sk/en/quality-assessement-of-medical-products/instructions/internationally-harmonized-requirements-for-batch-certification 2026-03-20 weekly https://www.sukl.sk/en/quality-assessement-of-medical-products/instructions/administrative-batch-release-of-vaccines-and-medicinal-products-derived-from-human-blood-or-plasma 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/korigendum-k-delegovanemu-nariadeniu-komisie-eu-2015-1011-z-24.-aprila-2015-ktorym-sa-doplna-nariadenie-europskeho-parlamentu-a-rady-eu-o-prekurzoroch-drog 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/corrigendum-to-the-commission-delegated-regulation-eu-2015-1011-of-24-april-2015-supplementing-regulation-ec-of-the-european-parliament-and-of-the-council-on-drug-precursors 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/prolia-denosumab-zavedenie-informacnej-karty-pacienta-ako-opatrenie-na-minimalizaciu-rizika-vzniku-osteonekrozy-celuste 2026-03-20 weekly https://www.sukl.sk/en/inspection/pharmacy/list-of-online-retailers 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/stanoviska-o-nezhodach-so-spravnou-velkodistribucnou-praxou 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola-/stanoviska-o-nezhodach-so-spravnou-velkodistribucnou-praxou/stanovisko-nezhody-so-spravnou-velkodistribucnou-praxou 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xgeva-denosumab-nova-kontraindikacia-a-zavedenie-informacnej-karty-pacienta-ako-opatrenie-na-minimalizaciu-rizika-vzniku-osteonekrozy-celuste 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/epirubicin-hydrochlorid-pokyny-pre-zdravotnickych-pracovnikov-na-zabranenie-moznych-omylov-v-davkovani 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/bioparox-fusafungin-nove-kontraindikacie-a-odporucania-k-minimalizacii-rizika-zavaznych-alergickych-reakcii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-doplnkov-8.-vydania-europskeho-liekopisu-v-roku-2016 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/aktualna-informacia-tykajuca-sa-prsnikovych-implantatov-od-vyrobcu-silimed-lndustria-de-lmplantes-ltda-brazilia 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/state-institute-for-drug-control-have-joined-the-cesp-system-for-a-pilot-phase 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-2.vydania-slovenskeho-farmaceutickeho-kodexu 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/aktualizacia-informacie-tykajucej-sa-implantatov-od-vyrobcu-silimed-lndustria-de-lmplantes-ltda-brazilia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/nove-internetove-logo-zaruci-bezpecnost-nakupu-liekov-cez-internet 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/media/news/european-commission-launches-a-new-mandatory-logo-for-online-sale-of-medicines-to-protect-patients-from-falsified-medicines 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/dokumenty 2024-06-17 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/dokumenty/zoznam-monografii-ph.-eur.-slovensko-anglicko-latinske-preklady-9.-vydanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/zakladne-informacie-pre-elektronicke-podavanie-dokumentacie-portalom-cesp 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/notification-about-the-possibility-to-submit-authorisation-applications-and-related-documents-through-the-cesp-portal 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/informacia-pre-ziadatelov-o-vydanie-povolenia-na-zaobchadzanie-s-urcenymi-latkami-kategorie-1-podla-zakona-c.-331-2005-z.-z.-a-drzitelov-povoleni-na-zaobchadzanie-s-urcenymi-latkami-kategorie-1-podla-zakona-c.-219-2003-z.-z 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zelboraf-vemurafenib-zosilnenie-toxicity-radioterapie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xalkori-krizotinib-upozornenia-tykajuce-sa-srdcoveho-zlyhania 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/informacia-pre-ziadatelov-o-vydanie-registracie-na-zaobchadzanie-s-urcenymi-latkami-kategorie-2-a-3-podla-zakona-c.-331-2005-z.-z.-a-drzitelov-povoleni-na-zaobchadzanie-s-urcenymi-latkami-kategorie-2-a-3-podla-zakona-c.-219-2003-z.-z 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/odklad-vykonatelnosti-rozhodnutia-mz-sr-c.-s-06484-op-2014-zo-dna-23.2.2015-v-spojeni-s-rozhodnutim-sukl-c.-3430-2012-600-zo-dna-02.05.2013 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/oznamy/aktualizacia-informacie-tykajucej-sa-implantatov-od-vyrobcu-silimed-lndustria-de-lmplantes-ltda-brazilia 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-44-2015 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/cellcept-mykofenolatmofetil-zavazne-riziko-teratogenity-odporucania-na-prevenciu-gravidity-pre-zeny-a-muzov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/thalidomide-celgene-talidomid-uvodna-davka-talidomidu-sa-ma-v-kombinacii-s-melfalanom-u-pacientov-vo-veku-nad-75-rokov-znizit 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/factor-vii-nf-baxter-koagulacny-faktor-vii-nepresnost-v-spc-a-pil 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tecfidera-dimetylfumarat-nove-pravidla-na-minimalizaciu-rizika-pml-zvysene-monitorovanie-a-pravidla-na-ukoncenie-liecby 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lidocain-egis-10-derm.rozt.aerodisperzia-zhrnutie-k-hlaseniu-o-kvalite 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/mykofenolat-mofetil-sandoz-myfenax-myfortic-mykofenolatmofetil-zavazne-riziko-teratogenity-odporucania-na-prevenciu-gravidity-pre-zeny-a-muzov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gilenya-fingolimod-rizika-suvisiace-s-ucinkami-na-imunitny-system 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/viekirax-a-viekirax-spolu-s-exvierou-sa-neodporucaju-u-pacientov-s-poskodenim-funkcie-pecene-triedy-b-podla-childa-pugha 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-zavadza-elektronicky-sposob-hlasenia-podozreni-na-nul 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-sukl-v-suvislosti-s-klinickym-skusanim-vo-francuzsku 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/electronic-application-forms-eafs-mandatory-for-all-precedures-from-january-2016 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2016 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky-informacie/registracia-vyrobcu-a-zp 2025-03-04 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky-informacie/informacie-tykajuce-sa-registracie-oznamenia-zp/oznamenie-vyrobcu-o-zp 2025-03-04 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tachosil-ludsky-fibrinogen-ludsky-trombin-nove-odporucania-na-zmiernenie-rizika-crevnej-obstrukcie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/krv-a-transfuzne-lieky/opatrenie-mz-sr-z-2.-januara-2016 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/spravna-prax-pripravy/oznamovanie-zavaznych-neziaducich-reakcii-a-udalosti-transfuznych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/laboratorna-kontrola/laboratorna-kontrola/mp-122-2016-postup-pri-podavani-ziadosti-o-uvolnenie-ockovacich-latok-a-liekov-vyrobenych-z-krvi-a-z-ludskej-plazmy-na-trh-v-slovenskej-republike-verzia-c.7 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/inhibitory-sglt2-invokana-vokanamet-forxiga-xinduo-jandiance-synjardy-aktualizovane-odporucania-pre-riziko-diabetickej-ketoacidozy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zaltrap-aflibercept-informacie-o-riziku-osteonekrozy-celuste 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tysabri-natalizumab-aktualizovane-opatrenia-na-minimalizovanie-rizika-progresivnej-multifokalnej-leukoencefalopatie-pml 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xofigo-radium-223-zmena-standardneho-referencneho-materialu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zydelig-idelalisib-obmedzenia-tykajuce-sa-pouzivania-lieku-po-novych-vysledkoch-klinickych-studii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-eu-sa-rusi-registracia-liekov-s-obsahom-fusafunginu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tarceva-erlotinib-indikacia-udrziavacej-liecby-prvej-linie-teraz-obmedzena-na-pacientov-ktorych-tumory-prechovavaju-aktivujucu-mutaciu-egrf 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/inhibitory-bcr-abl-tyrozinkinaz-imatinib-dasatinib-nilotinib-bosutinib-ponatinib-potreba-skriningu-pacientov-na-pritomnost-virusu-hepatitidy-b-pred-liecbou-v-dosledku-rizika-reaktivacie-hepatitidy-b 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/bioparox-fusafungin-lieky-s-obsahom-fusafunginu-na-ustne-a-nosove-pouzitie-nebudu-viac-dostupne-na-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/imnovid-palidomid-pred-zacatim-liecby-palidomidom-sa-ma-stanovit-status-hepatitidy-b 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-45-2016 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-28.2 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/invokana-kanagliflozin-a-vokanamet-kanagliflozin-metformin-riziko-amputacii-dolnej-koncatiny-predovsetkym-prstov-na-nohe 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny/informacia-o-povinnosti-mah-predkladat-vsetky-psur-do-centralneho-psur-repozitata-od-13.6.2016 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2015 2016-05-10 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/cinnost-sukl-v-roku-2015 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-hostil-odborny-seminar-zamerany-na-detekciu-signalov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/implementacia-internetoveho-loga-a-podpisanie-sublicencnych-zmluv-o-pouzivani-loga 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tematicky-kurz-sarap-venovany-teme-zdravotnicke-pomocky 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/nariadenie-rady-es-c.-111-2005-z-22.-decembra-2004-ktorym-sa-stanovuju-pravidla-sledovania-obchodu-s-drogovymi-prekurzormi-medzi-es-a-tretimi-krajinami-v-platnom-zneni 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/nariadenie-es-c.-273-2004-europskeho-parlamentu-a-rady-z-11.-februara-2004-o-prekurzoroch-drog-v-platnom-zneni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/erivedge-vismodegib-riziko-predcasnej-fuzie-epifyz 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/distribucia/usmernenia-z-5.-novembra-2013-k-spravnej-distribucnej-praxi-liekov-na-humanne-pouzitie 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/oddelenie-spravnej-vyrobnej-a-velkodistribucnej-praxe/pokyny-es-k-spravnej-vyrobnej-praxi-good-manufacturing-practice-gmp-guidelines 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/zakladne-informacie-o-reklame-liekov 2016-06-23 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/hlasenia-o-reklame 2025-03-26 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/zakladne-informacie-o-reklame-liekov/vseobecne-poziadavky-na-reklamu-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/zakladne-informacie-o-reklame-liekov/reklama-liekov-zamerana-na-laicku-verejnost 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/zakladne-informacie-o-reklame-liekov/reklama-liekov-zamerana-na-odbornu-verejnost 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/zakladne-informacie-o-reklame-liekov/priklady-z-praxe-rozhodnutia-sukl 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/thalidomide-celgene-talidomid-riziko-virusovej-reaktivacie-a-plucnej-hypertenzie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prioritou-sukl-v-case-eu-predsednictva-bude-najma-optimalizacia-regulacnych-procesov-a-riesenie-temy-nedostupnosti-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-28.3 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/adempas-riociguat-nova-kontraindikacia-u-pacientov-s-plucnou-hypertenziou-suvisiacou-s-idiopatickymi-intersticialnymi-pneumoniami-ph-iip 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/neotigason-acitretin-zavazne-riziko-teratogenity-a-riziko-so-subeznou-konzumaciou-alkoholu-a-darovanim-krvi 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2015 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/informacia-o-vydanom-predbeznom-opatreni-ing.-andrej-dzadon-medservis 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/dodatok-c.-1-ku-kontraktu-medzi-mz-sr-a-sukl-na-rok-2016 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/delegovane-nariadenie-komisie-eu-2016-1443-z-29.-juna-2016-ktorym-sa-meni-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-a-nariadenie-rady-es-c.-111-2005-pokial-ide-o-zaradenie-urcitych-drogovych-prekurzorov-do-zoznamu-urcenych-latok 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/commission-delegated-regulation-eu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zydelig-idelalisib-aktualizacia-opatreni-na-minimalizovanie-rizika-zavaznych-infekcii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-bratislave-zasadali-riaditelia-liekovych-agentur 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/media/news/the-heads-of-medicines-agencies-was-held-in-bratislava 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-9.-vydania-europskeho-liekopisu 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/announcement-of-a-maintenance-of-the-information-system-of-sidc 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-46-2016 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/sunset-clause 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/odborne-usmernenie-ministerstva-zdravotnictva-slovenskej-republiky-c.-of-0504-2016-z-18.-augusta-2016-ktorym-sa-usmernuje-pocet-baleni-lieku-s-obsahom-drogoveho-prekurzora-potrebnych-na-jeden-liecebny-cyklus 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/lisvy-stiahnutie-lieku-z-dovodu-odchylky-od-registrovanej-specifikacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/blincyto-blinatumomab-riziko-pankreatitidy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-28.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-spusta-kampan-na-hlasenie-podozreni-na-vedlajsie-ucinky-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/revlimid-lenalidomid-nove-dolezite-odporucania-tykajuce-sa-virusovej-reaktivacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/otezla-apremilast-nove-dolezite-informacie-o-suicidalnych-predstavach-a-chovani 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/predsednicke-zasadnutia-sukl-pokracovali-temou-zdravotnickych-pomocok-a-komunikacie-s-verejnostou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/media/news/in-october-the-sidc-presidency-meetings-focused-on-medical-devices-issues-and-public-relations 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-47-2016 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/keppra-100-mg-ml-peroralny-roztok-levetiracetam-riziko-vyskytu-chyb-v-liecbe-spojenych-s-predavkovanim 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-a-uskvbl-hostovali-po-druhykrat-zasadnutie-riaditelov-liekovych-agentur 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/media/news/slovak-human-and-veterinary-medicines-agencies-hosted-the-second-meeting-of-the-heads-of-medicines-agencies 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ammonaps-natriumfenylbutyrat-tablety-sa-maju-pouzivat-iba-v-pripade-ak-nie-je-k-dispozicii-ziadna-alternativna-liecba 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cometriq-cabozantinib-zastarana-verzia-pisomnej-informacie-pre-pouzivatela-v-niektorych-baleniach 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/posobnost 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/posobnost/liekopisne-oddelenie 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/dokumenty/linky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-29.1 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2017 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/vyhlaska-mz-sr-c.-158-2015-spravna-prax-pripravy-transfuznych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/vyhlaska-mz-sr-c.-334-2015-ktorou-sa-meni-a-doplna-vyhlaska-mz-sr-c.-158-2015-z.-z.-o-poziadavkach-na-spravnu-prax-pripravy-transfuznych-liekov 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2017 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/28.-februar-je-medzinarodny-den-zriedkavych-chorob 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/depocyte-sus-inj-1x5-ml-50-mg-lipozomalny-cytarabin-informacia-oobmedzenych-dodavkach-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/herceptin-trastuzumab-pripomenutie-dolezitosti-usmernenia-pre-sledovanie-funkcie-srdca-s-cielom-znizit-vyskyt-a-zavaznost-dysfunkcie-lavej-komory-a-kongestivneho-srdcoveho-zlyhania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pradaxa-dabigatranetexilat-zmena-farby-kapsul-pradaxa-75-mg-pradaxa-110-mg-a-pradaxa-150-mg 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/levact-bendamustin-zaznamenanie-zvysenej-umrtnosti-v-ramci-poslednych-studii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/erythromycini-ethylsuccinas-0274-rychla-implementacia 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/clexane-enoxaparin-sodny-upresnenie-vyjadrenia-sily-davkovania-pri-hlbokej-zilovej-tromboze-hzt-plucnej-embolizacii-pe-a-pouzitia-u-pacientov-so-zavaznou-poruchou-funkcie-obliciek 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2016 2017-04-13 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/cinnost-sukl-v-roku-2016 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-29.2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cotellic-kobimetinib-upozornenia-tykajuce-sa-krvacania-a-rabdomyolyzy-vratane-novych-odporucani-na-upravu-davky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tematicky-kurz-sarap-venovany-teme-pharmacovigilance-regulatory 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/korigendum-k-delegovanemu-nariadeniu-komisie-eu-2015-1011z-24.-aprila-2015-ktorym-sa-doplna-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-o-prekurzoroch-drog-a-nariadenia-rady-es-c.-111-2005-ktorym-sa-stanovuju 2026-03-20 weekly https://www.sukl.sk/en/drug-precursors/legislation-on-drug-precursors/corrigendum-to-commision-delegated-regulation-eu-2015-1011-of-24-april-2015-supplementig-regulation-ec-no-273-2004-of-the-european-parliament-and-of-the-coucil-on-drug-precursors-and-council-regulation-ec-no-111-2005-laying-down-rules-for-the-monitoring-of-trade-between-the-union-and-third-countries-in-drug-precursors-and-repealing-commision-regulation-ec-no-1277-2005 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/nove-nariadenia-o-zdravotnickych-pomockach-nadobudli-ucinnost 2026-03-20 weekly https://www.sukl.sk/sk/o-nas/zakladne-dokumenty/plan-rozvoja-sukl-na-roky-2016-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/depocyte-sus-inj-1x5-ml-50-mg-lipozomalny-cytarabin-aktualizacia-informacie-o-obmedzenych-dodavkach-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/studie-bezpecnosti-lieku/zaverecne-spravy-studii/polyoxidonium-enceep 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-komisia-hlada-vedeckych-expertov-na-poziciu-nezavisleho-prac-experta 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ketoconazole-hra-200-mg-tablety-ketokonazol-informacia-o-riziku-hepatotoxicity 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-ema-uskutocni-prve-verejne-vypocutie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhcpzinbrytabiogen-slovakia13-07-2017.pdf-zinbryta-daklizumab-obmedzenie-pouzitia-o-ohladom-na-fatalne-zlyhanie-pecene 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/formaty-registracnej-dokumentacie-predkladanej-na-sukl 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/imbruvica-iibrutinib-riziko-reaktivacie-hepatitidy-b-pred-zacatim-liecby-liekom-imbruvica-sa-ma-zistit-stav-virusu-hepatitidy-b. 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/trisenox-oxid-arzenity-zvazte-alternativne-moznosti-liecby-u-niektorych-novodiagnostikovanych-pacientov-pre-hroziaci-nedostatok-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-29.3 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/metylprednizolon-40-mg-s-obsahom-laktozy-prosba-o-posudenie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gentamicin-sandozr-80-mg2-ml-injekcny-roztok-stopove-mnozstvo-histaminu-v-liecive 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/prehlad-koordinatorov-pre-drzitelov-registracie 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prieskum-o-hlaseni-podozreni-na-neziaduce-ucinky-liekov 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/submission-of-the-marketing-authorisation-applications-via-dc-mr-procedures-national-requirements 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/aranesp-neorecormon-mincera-binocrit-biopoin-ludske-epoetiny-nove-upozornenia-na-zavazne-kozne-reakcie 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/exjade-filmom-obalene-tablety-deferasirox-riziko-pochybenia-v-liecbe-pri-novej-liekovej-forme 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/annual-reports/annual-report-2016 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europsky-audit-bema-iv 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-29.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fingolimod-gilenya-kontraindikacie-u-pacientov-s-ochorenim-srdca 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/misoprostol-misodel-hlasenia-nadmernych-kontrakcii-ktore-nemusia-reagovat-na-tokolyticku-liecbu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/daklizumab-zinbryta-obmedzenia-v-pouzivani-v-suvislosti-s-rizikom-fulminantneho-zlyhania 2026-03-20 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/enterol-saccharomyces-boulardii-kontraindikacia-u-kritickych-chorych-alebo-imunokompromitovanych-pacientov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/informacie-o-vyskyte-falzifikatov-lieku-sprycel 2022-04-05 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/eligard-leuproleliniumacetat-chyby-v-liecbe-spojene-s-unikom-lieku-sposobene-prilisnym-utiahnutim-bezpecnostnej-ihly 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/litak-kladribin-riziko-progresivnej-multifokalnej-leukoencefalopatie-plm 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/exjade-deferasirox-ukoncenie-dodavok-dispergovatelnych-tabliet 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/falzifikat-lieku-velcade-zachyteny-v-holandsku 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/falzifikaty-liekov-artipla-a-avonex-zachytene-v-nemecku 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-balenia-liekov-baraclude-a-benepali 2022-04-05 weekly https://www.sukl.sk/sk/bezpecnost-liekov/oznamy-drzitelov/kontrastne-latky-obsahujuce-gadolinium-aktualizovane-odporucania-po-revizii-retencie-gadolinia-v-mozgu-a-inych-tkanivach 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-48-2017 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-doplnkov-9.-vydania-europskeho-liekopisu-v-roku-2018 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ambrobene-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ventilastin-novolizer-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-stopangin-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-30.1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/postregistracna-kontrola-kvality/mp-112-2017-poziadavky-na-preznacovanie-casu-pouzitelnosti-verzia-c.3 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cellcept-myfortic-myfenax-mykofenolat-mofetil-sandoz-mofetilmykofenolat-mmf-kyselina-mykofenolova-mpa-upravene-odporucania-na-antikoncepciu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/informacie-o-vyskyte-falzifikatu-lieku-alimta 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-upozornuje-na-internetovy-predaj-liekov-neznameho-povodu 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-synjardy-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-upozornuje-na-internetovy-predaj-liekov-neznameho-povodu 2018-02-23 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/spolupraca-statneho-ustavu-pre-kontrolu-lieciv-sr-a-rakuskej-liekovej-agentury-ages 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-velcade-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stretnutia-generalnej-tajomnicky-sluzobneho-uradu-a-riaditelky-sukl-bratislava-s-prezidentom-slovenskej-lekarnickej-komory 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-beloderm-lotion-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/slovensko-vstupuje-do-centralizovaneho-procesu-hodnotenia-liekov-v-eu 2026-03-20 weekly https://www.sukl.sk/en/inspection/pharmacy/online-dispensing 2026-03-20 weekly https://www.sukl.sk/en/inspection/post-authorisation-quality-control/recall-of-medicinal-products 2026-03-20 weekly https://www.sukl.sk/en/inspection/post-authorisation-quality-control/information-on-falsified-medicines 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ciprofloxacin-kabi-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-chamomilla-teva-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stretnutie-zastupcov-sukl-a-sool 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/edukacne-materialy 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/esmya-ulipristalacetat-obmedzenie-pouzitia-dolezite-nove-varovania-upozornujuce-na-zavazne-poskodenie-pecene-a-odporucania-pre-sledovanie-pecenovych-funkcii 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-balenia-lieku-mandolgin 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-v-taliansku 2022-04-05 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-zoledronat-stada-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny/aktualizacia-pokynov-tykajucich-sa-zasielania-hlaseni-podozreni-na-neziaduce-ucinky-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-s-novym-dizajnom-web-stranky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/registracie-v-roku-2017 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusene-registracie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusene-lieky-v-roku-2017 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/falzifikat-lieku-cellcept-zachyteny-v-nemecku 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/ema-odporucila-okamzite-pozastavenie-registracie-lieku-zinbryta-a-jeho-stiahnutie-z-obehu 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-bondulc-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac 2018-07-23 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-5.-8.-marec-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zinbryta-daklizumab-beta-pozastavenie-rozhodnutia-o-registracii-v-europskej-unii 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/bezpecnostne-prvky 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xofigo-chlorid-radnaty-223-kontraindikovany-v-kombinacii-s-abirateonom-a-prednizonom-prednizolonom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/doreta-sr-75mg-650-mg-tablety-paracetamol-tramadol-docasne-pozastavenie-rozhodnutia-o-registracii-pre-komplexnost-a-obtaznost-liecby-predavkovania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-maxipime-23.3.2018.pdf-maxipime-1-g-cefepim-riziko-zavaznych-neziaducich-reakcii-u-pacientov-s-poruchou-funkcie-obliciek-ktori-dostali-davky-prekracujuce-odporucania 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-infadolan-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/schvalenie-novych-opatreni-v-suvislosti-s-valproatom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-eu-schvalili-zrusenie-registracie-liekov-s-obsahom-flupirtinu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/ziadost-vzdanie-sa-odvolania-a-vyznacenie-pravoplatnosti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpctrisenox23-3-2018-.pdf-trisenox-oxid-arzenity-pocas-nedostatku-dodavok-na-trh-je-nahrada-liekom-phenasen 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-na-socialnych-sietach 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/verejne-vypocutie-na-temu-chinolonove-a-fluorochinolonove-antibiotika 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-vyzyva-na-zapojenie-sa-do-verejneho-vypocutia-ohladom-antibiotik 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/producta-ab-fermentatione-1468-rychla-implementacia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/expertmi-odsuhlasene-informacie-o-biologicky-podobnych-liekoch 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-9.-12.-april-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-30.2 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/instructions/form-for-submitting-clinical-trial-documents-to-the-sidc 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2017 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusene-registracie-vo-februari-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-katadolon9-4-2018.pdf-katadolon-flupirtin-lieky-obsahujuce-flupirtin-uz-viac-nebudu-dostupne-na-trhu-eu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-azithromycin-2-5-2018.pdf-azitromycin-zvysena-miera-relapsov-hematologickych-malignit-a-mortality-u-pacientov-po-transplantacii-hematopoetickych-kmenovych-buniek-hsct-liecenych 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/edukacne-materialy/oznam-o-zverejnovani-edukacnych-materialov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-49-2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/pritomnost-pyrolizidinovych-alkaloidov-v-rastlinnych-liekoch 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-v-rumunsku-aktualizacia 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xgeva-denosumab-rizika-novych-primarnych-malignit 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/moznost-odberu-noviniek-z-webovych-stranok-sukl 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/delegovane-nariadenie-2018-729-anpp-a-npp 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-14.-17.-maj-2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-z-talianskej-nemocnicnej-lekarne 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-v-taliansku-maj-2018 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tivicay-dolutegravir-triumeq-dolutegravir-abakavir-lamivudin-juluca-dolutegravir-rilpivirin-defekty-neuralnej-trubice-hlasene-u-dojciat-narodenych-zenam-liecenym-dolutegravirom-v-case-pocatia 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=4891 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tematicky-kurz-sarap-venovany-teme-nove-legislativne-prostredie-v-oblasti-zdravotnickych-pomocok-a-registracie-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/navsteva-predstavitelov-holandskej-liekovej-agentury-v-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusene-registracie-v-marci-2018 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/memorandum-o-spolupraci-so-szu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-pocas-transportu-v-taliansku 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/stanoviska-o-nezhodach-so-spravnou-velkodistribucnou-praxou/stanovisko-nezhody-so-spravnou-velkodistribucnou-praxou-sofar 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-11.-14.-jun-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-cetrotide-025-mg-cetrorelix-acetat-prasok-a-rozpustadlo-na-injekcny-roztok-riziko-vytrhnutia-piestu-z-novej-injekcnej-striekacky-pri-natahovani-lieku-s-naslednou-stratou-sterili 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-pocas-transportu-v-rakusku 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/formaty-registracnej-dokumentacie-predkladanej-na-sukl-od-1.7.2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-keytruda-obmedzenie-indikacii-v-liecbe-lokalne-pokrocileho-alebo-metastatickeho-urotelialneho-karcinomu-u-dospelych-u-ktorych-nie-je-vhodna-liecba-chemoterapiou-obsahujucou-cisplatinu 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-vasopentol-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-valsartan-actavis-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-vapress-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-valzap-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-informuje-o-stiahnuti-liekov-s-ucinnou-latkou-valsartan-z-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-esmya-nova-kontraindikacia-poziadavky-na-monitorovanie-pecene-a-obmedzenie-indikacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-tecentriq-obmedzenie-indikacii-v-liecbe-lokalne-pokrocileho-alebo-metastatickeho-urotelialneho-karcinomu-u-dospelych-pre-ktorych-nie-je-vhodna-liecba-chemoterapia-na-baze-cispla 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizovane-informacie-o-stiahnuti-liekov-s-obsahom-ucinnej-latky-valsartan-z-trhu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-pocas-transportu-v-taliansku-1 2018-07-09 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzene-lieky-pocas-transportu-v-taliansku-14.-6.-2018 2018-07-12 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-daxas 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-9.-12.-jul-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusene-registracie-v-aprili-2018 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=4934 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dhpc-spinraza 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie 2018-07-23 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie/sarap-2012 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie/sarap-2013 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie/sarap-2015 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie/sarap-2017 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie/sarap-2018 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/administrative-fee-refund-application 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/infuzne-roztoky-hydroxyetylskrobu-hes-nove-opatrenia-na-posilnenie-existujucich-obmedzeni-kvoli-zvysenemu-riziku-renalnej-dysfunkcie-a-mortality-u-kriticky-chorych-pacientov-a-pacien 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/metodicke-pokyny-pre-ziadatelov-o-vydanie-povoleni-na-vyrobu-a-velkodistribuciu-humannych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-30.3 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizacia-informacii-o-preskumani-liekov-s-ucinnou-latkou-valsartan 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/usmernenie-ku-konaniu-referral-procedure-emea-h-a-31-1454-pre-valproany-a-podobne-ucinne-latky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xofigo-chlorid-radnaty-223-nove-obmedzenia-pouzivania-v-dosledku-zvyseneho-rizika-zlomenin-a-trendu-k-zvysenej-umrtnosti 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny/usmernenie-ku-konaniu-referral-procedure-emea-h-a-31-1454-pre-valproany-a-podobne-ucinne-latky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zinbryta-daklizumab-beta-pripady-imunitne-sprostredkovanej-encefalitidy-vratane-encefalitidy-s-protilatkami-proti-nmda-receptorom-hlasene-niekolko-mesiacov-po-ukonceni-liecby 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/biologicky-podobne-lieky-nie-su-napodobneniny 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/riziko-aortitidy-pre-liekovu-skupinu-faktorov-stimulujucich-kolonie-granulocytov-g-csf-filgrastim-lenograstim-lipegfilgrastim-pegfilgrastim 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-50-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/novy-sadzobnik-vykonov-a-sluzieb 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusene-registracie-v-juni-a-juli-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/varovanie-pred-internetovym-predajom-neregistrovanych-liekov-urcenych-na-liecbu-erektilnej-dysfunkcie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/odcudzenie-liekov-v-talianskej-nemocnicnej-lekarni-12.-9.-2018 2018-09-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-thiopental-z-trhu 2026-04-14 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/sukl-varuje-pre-nakupom-zdravotnickych-pomocok-cez-zlavovy-klub 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/keppra-levetiracetam-aktualizacia-udajov-o-pouzivani-pocas-tehotenstva 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ozurdex-z-trhu-aktualizacia 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xarelto-rivaroxaban-narast-poctu-umrti-u-pacientov-po-transkatetrovej-vymene-aorrtalnej-chlopne-v-predcasne-ukoncenom-klinickom-skusani 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ozurdex-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tematicky-kurz-sarap-venovany-temam-legislativne-zmeny-a-ich-implementacia-v-prostredi-registracie-liekov-v-sr-a-implementacia-fmd 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/sildenafil-revatio-a-viagra-sa-nema-pouzivat-na-liecbu-vnutromaternicovej-retardacie-rastu-plodu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-30.4 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-3.-6.9.2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-1.-4.10.2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/informacie-o-databaze-liekov-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/hydrochlorotiazid-riziko-nemelanomovej-rakoviny-koze-bazocelularny-karcinom-skvamocelularny-karcinom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/zoznam-vyrobcov 2018-10-18 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/zoznam-velkodistributorov 2018-10-18 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/retinoidy-acitretin-adapalen-alitretinoin-bexaroten-izotretinoin-tazaroten-a-tretinoin-aktualizovane-informacie-o-teratogenite-a-psychickych-poruchach 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fluorchinolony-na-systemove-a-inhalacne-pouzitie-riziko-aneuryzmy-a-disekcie-aorty 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/zrusenia-registracnych-rozhodnuti-v-sulade-s-56-ods.-4-zakona-o-lieku-c.-362-2011 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/list-zainteresovanym-stranam-o-uplatnovani-bezpecnostnych-prvkov 2022-04-05 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-podozrivych-baleniach-lieku-mabthera-zachytenych-v-nemecku 2018-10-26 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-podozrivych-baleniach-lieku-seebri-breezhaler-zachytenych-v-nemecku 2018-10-26 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/nedostupnost-lieku-rivotril 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prepojenie-na-databazu-europskej-liekovej-agentury 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-51-2018 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-sa-zapaja-do-svetoveho-tyzdna-povedomia-o-antibiotikach 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-oodcudzeni-liekov-vrumunsku 2018-11-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/valproat-nove-obmedzenia-uzivania-zavedenie-programu-prevencie-tehotenstva 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-kampan-na-podporu-hlaseni-neziaducich-ucinkov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-odcudzeni-liekov-v-taliansku 2018-11-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/mp-132-2018-kriteria-pre-hodnotenie-povoleneho-rozmedzia-obsahu-ucinnych-latok-a-celkovych-hmotnosti-alebo-objemov-liekov-pripravovanych-v-lekarnach 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-pleumolysin-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/elektronicke-podanie-ziadosti/formaty-registracnej-dokumentacie-predkladanej-na-sukl-od-1.1.2019 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-informuje-o-falsovanych-baleniach-lieku-avastin-zachytenych-v-madarsku 2018-12-18 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-informuje-o-falsovanych-baleniach-lieku-iclusig-zachytenych-v-turecku-aktualizacia 2019-03-13 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-doplnkov-9.-vydania-europskeho-liekopisu-v-roku-2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xyrem-natriumoxybat-500-mg-ml-peroralny-roztok-riziko-predavkovania-alebo-nedostatocneho-davkovania-z-dovodu-postupneho-zhorsovania-citatelnosti-oznacenia-na-odmernej-striekacke-liek 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-informuje-o-falsovanom-baleni-lieku-alimta-zachytenom-v-nemecku 2019-01-10 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-vitamin-c-injektopas-75-g-sol-inf-liek.inj.skl.hneda-1x50-ml 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/opatrenie-mz-sr-z-2.-januara-2016-c.-s06601-ol-2015 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/legislativa/opatrenie-mz-sr-z-9.-novembra-2017-ktorym-sa-meni-a-doplna-opatrenie-ministerstva-zdravotnictva-slovenskej-republiky-z-2.-januara-2016-c.-s06601-ol-2015 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizacia-informacii-o-bezpecnostnych-prvkoch 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/vyzva-pre-drzitelov-rozhodnutia-o-registracii-na-implementaciu-casti-17-a-18-u-liekov-ktore-musia-byt-vybavene-bezpecnostnymi-prvkami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/inhibitory-sglt2-riziko-fournierovej-gangreny-nekrotizujucej-fasciitidy-perinea-pri-pouzivani-inhibitorov-kotransportera-sodika-a-glukozy-2-sglt2i 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/kyselina-deoxycholova-belkyra-10-mg-ml-riziko-nekrozy-v-mieste-podania-injekcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-pripomienkovani-clankov-navrhovanych-do-paediatric-formulary 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ibalgin-200-a-ibalgin-400-pridanie-novej-pomocnej-latky-monohydrat-laktozy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-informuje-o-odcudzeni-liekov-vo-velkej-britanii 2019-01-22 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-irbesartan-actavis-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-olynth-ha-01-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-nariadil-stiahnutie-lieku-olynth-ha-01-z-urovne-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-31.1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lartruvo-olaratumab-vysledky-vyziadanej-post-registracnej-studie-nepotvrdili-klinicky-benefit-olaratumabu-v-schvalenej-indikacii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-verejnej-konzultacii-v-oblasti-skusok-disolucie-na-stranke-edqm 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/usmernenie-slek-a-sool-k-overovaniu-bezpecnostnych-prvkov-liekov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-informuje-o-odcudzeni-liekov-v-taliansku 2019-02-06 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-obsahujuce-karbimazol-alebo-tiamazol-synonymum-metimazol-1-riziko-akutnej-pankreatitidy-a-2-dorazne-odporucanie-antikoncepcie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-informuje-o-podozreni-na-vyskyt-falsovanych-liekov-v-nemecku 2019-02-07 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-irbesartan-actavis-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/spolocne-vyhlasenie-sukl-a-sool-k-spusteniu-noveho-systemu-na-overovanie-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/lieky-s-obsahom-sartanov-testovanie-sarzi-a-preskumanie-vyrobnych-procesov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizacia-zoznamov-vyrobcov-a-velkodistributorov 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2019 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/vyhodnotenie-kontraktu-za-rok-2018-medzi-mz-sr-a-sukl 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/vyhlasenie-o-zaujmoch 2026-04-08 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/brexit-bez-dohody-a-zdravotnicke-pomocky-pokyny-pre-vyrobcov-a-splnomocnencov-dovozcov-a-distributorov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/intravitrealny-implantat-ozurdexr-700-mikrogramov-dexametazon-aktualizovane-informacie-k-problemu-so-silikonovymi-casticami-dodavka-novych-zasob-bez-nedostatku-v-kvalite 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-odcudzeni-liekov-v-taliansku-1 2019-03-12 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/pozastavenie-vyroby-v-spolocnosti-unimed-pharma-s.r.o 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-lopridam-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-vyzyva-na-obmedzenie-pouzivania-fluorochinolonovych-antibiotik 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/belimumab-benlysta-zvysene-riziko-zavaznych-psychickych-udalosti-depresia-samovrazedne-myslienky-samovrazedne-spravanie-alebo-sebaposkodenie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/genvoyar-elvitegravir-kobicistat-emtricitabin-tenofoviralafenamid-stribildr-elvitegravir-kobicistat-emtricitabin-tenofovir-dizoproxil-zvysene-riziko-zlyhania-liecby-a-zvysene-riziko-prenosu-infekcie-hiv-z-matky-na-dieta 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xeljanz-tofacitinib-zvysene-riziko-plucnej-embolie-a-mortality-u-pacientov-s-reumatoidnou-artritidou-ktori-v-klinickom-skusani-uzivali-tofacitinib-v-davke-10-mg-dvakrat-denne 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2018 2022-04-05 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-omeprazol-mylan-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/systemove-a-inhalacne-chinolonove-a-fluorchinolonove-antibiotika-riziko-dlhotrvajucich-invalidizujucich-a-potencialne-ireverzibilnych-neziaducich-ucinkov-a-obmedzenia-ich-pouzivania 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/nedostupnost-lieku-lexaurin 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizacia-informacii-k-pozastaveniu-vyroby-v-unimed-pharma 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-52-2019 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola/prerusenia-dodavok-liekov-v-sr/oznam-pre-drzitelov-registracii-oznamenia-o-preruseni-zruseni-alebo-obnoveni-dodavok-humanneho-lieku-na-slovensky-trh 2022-04-05 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-conoxia-stlaceny-medicinalny-plyn-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/upozornenie-na-zmenu-skladovacich-podmienok-lieku-haemocomplettan-1g-a-2g 2026-03-20 weekly https://www.sukl.sk/o-nas/verejne-obstaravanie/zakazka-s-nizkou-hodnotou 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-31.2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/alemtuzumab-lemtrada-obmedzenie-pouzivania-z-dovodu-zavaznych-bezpecnostnych-problemov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/odpovede-na-otazky-o-biologickych-liekoch 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-pleumolysin-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lartruvo-olaratumab-zrusenie-povolenia-na-uvedenie-na-trh-v-eu-z-dovodu-nedostatocnej-terapeutickej-ucinnosti 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-falsovanych-baleniach-lieku-soliris-zachytenych-v-belgicku 2019-05-17 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-falsovanych-baleniach-lieku-avastin-zachytenych-v-holandsku 2019-05-17 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lapatinib-tyverb-dolezita-aktualizacia-suhrnu-charakteristickych-vlastnosti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/apixaban-eliquis-dabigatranetexilat-pradaxa-edoxaban-lixiana-roteas-a-rivaroxaban-xarelto-sa-neodporucaju-pacientom-s-antifosfolipidovym-syndromom-z-dovodu-mozneho-zvyseneho-rizika-r 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-odcudzeni-liekov-v-nemecku 2019-05-23 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-13.-16.5.2019 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-29.-31.10.2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-26.-29.11.2018 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-14.-17.1.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xeljanz-tofacitinib-obmedzenie-uzivania-tofacitinibu-v-davke-10-mg-dvakrat-denne-u-pacientov-so-zvysenym-rizikom-plucnej-embolie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/oznamenia-o-preruseni-zruseni-a-obnoveni-dodavok-liekov 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5120 2019-06-03 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-8.-11.4.2019 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-falsovanom-baleni-lieku-xarelto-zachytenom-v-anglicku-aktualizacia 2019-11-29 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/oznam-o-znizovani-administrativnej-zataze-vypis-z-registra-trestov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-12.-15.3.2019 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-11.-14.2.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tematicky-kurz-sarap-venovany-novinkam-z-oblasti-registracie-liekov-v-sr-implementacii-fmd-a-skusenosti-z-praxe-po-9.2.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/infuzne-roztoky-hydroxyetylskrobu-hes-dalsie-opatrenia-na-posilnenie-existujucich-opatreni 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-11.-14.6.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/darzalex-daratumumab-riziko-reaktivacie-virusu-hepatitidy-b 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/roactemrar-tocilizumab-zriedkave-riziko-zavazneho-poskodenia-pecene-vratane-akutneho-zlyhania-pecene-vyzadujuceho-transplantaciu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/adenuric-abuxar-a-febuxostat-sandoz-febuxostat-zvysene-riziko-kardiovaskularnej-smrti-a-mortality-zo-vsetkych-pricin-u-pacientov-liecenych-febuxostatom-v-studii-cares 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-elotrace-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-egilok-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-nariadil-stiahnutie-lieku-egilok-25-mg-az-z-urovne-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-31.3 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-adrenalin-bradex-ztrhu 2026-04-14 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/prechod-na-alfanumericke-kody-zdravotnickych-pomocok 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/dohoda-eu-us-mutual-recognition-agreement-o-uznavani-inspekcii-spravnej-vyrobnej-praxe 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-elotrace-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-8.-11.7.2019 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/audit-europskeho-riaditelstva-pre-kvalitu-liekov-a-zdravotnu-starostlivost-v-statnom-ustave-pre-kontrolu-lieciv 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/obnovenie-vyroby-ocnych-liekov-v-unimed-pharma 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/databaza-registrovanych-liekov-datum-registracie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/sukl-informuje-o-falsovanych-baleniach-lieku-gardasil-9-zachytenych-v-hong-kongu 2019-08-02 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/automaticke-prepojenie-na-databazu-europskej-liekovej-agentury 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/eliquis-apixaban-pisomna-informacia-lieku-eliquis-5-mg-v-baleni-eliquis-25-mg 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lynparza-olaparib-riziko-chyb-v-liecbe-v-suvislosti-s-novou-liekovou-formou 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-conoxia-stlaceny-medicinalny-plyn-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-endiex-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-na-parenteralnu-vyzivu-ochrana-pred-svetlom-je-nevyhnutna-pre-znizenie-rizika-zavaznych-neziaducich-ucinkov-u-predcasne-narodenych-novorodencov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dolezite-informacie-o-liecivom-pripravku-beriate 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gilenya-fingolimod-nova-kontraindikacia-u-gravidnych-zien-a-u-zien-vo-fertilnom-veku-ktore-nepouzivaju-ucinnu-antikoncepciu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vysvetlenie-premedikacie-s-dexametazonom-u-pediatrickych-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/otvorenie-noveho-klientskeho-centra 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/euthyrox-levotyroxin-tablety-so-zmenenym-zlozenim-pomocnych-latok-sledovanie-pacientov-prechadzajucich-na-tablety-so-zmenenym-zlozenim-pomocnych-latok 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-2.-5.9.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/metotrexat-v-indikacii-autoimunitnych-ochoreni-odporucania-pri-podavani-metotrexatu-pre-vyvarovanie-sa-moznych-fatalnych-nasledkov-nespravneho-davkovania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/reklama-liekov/zakladne-informacie-o-reklame-liekov/pokyny-pre-ziadatelov-o-suhlasne-stanovisko-k-ziadosti-o-povolenie-ockovacej-kampane 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-arnetin-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ranisan-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ranital-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stiahnutie-liekov-s-obsahom-ranitidinu 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/edukacne-materialy/archiv-edukacnych-materialov 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/edukacne-materialy/oznam-pre-drzitelov-o-archivovani-edukacnych-materialov-po-skonceni-povinnosti-ich-distribucie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-30.9.-3.10.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tematicky-kurz-sarap-venovany-zmene-vydaja-liekov-edukacnym-materialom-a-zdravotnickym-pomockam-v-zmysle-novej-legislativy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-28.-31.10.2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/drzitelia-rozhodnuti-o-registracii-liekov-maju-zhodnotit-riziko-pritomnosti-nitrozoaminov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/buducnost-antibiotik-zavisi-od-kazdeho-z-nas 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-31.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medsafetyweek-tyzden-povedomia-o-hlaseni-neziaducich-ucinkov-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/increlex-mekasermin-riziko-benignej-a-malignej-neoplazie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-25.-28.11.2019 2026-03-20 weekly https://www.sukl.sk/en/servis/search/database-of-medical-devices 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/informacie-o-pritomnosti-necistoty-ndma-v-niektorych-liekoch-s-obsahom-metforminu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/posobnost/referaty-topolcany-zilina-kosice-a-zvolen-zmena-miesta-vykonu-cinnosti 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ranisan-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/informacia-pre-drzitelov-povolenia-na-poskytovanie-lekarenskej-starostlivosti-oznacenia-v-jazyku-narodnostnych-mensin 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/liek-suboxone-dovoz-cudzojazycnych-baleni 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-53-2019 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/aktualizovany-zoznam-monografii-europskeho-liekopisu-latinske-anglicke-a-slovenske-nazvy 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/zrusenie-registracie-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/poplatky/sadzobnik-vykonov-a-sluzieb 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/poplatky/spravne-poplatky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postup-pri-podavani-ziadosti-o-zrusenie-rozhodnutia-registracie-lieku 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ecalta-100-mg-prasok-na-infuzny-koncentrat-anidulafungin-infuzny-roztok-sa-nesmie-zmrazovat 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lemtrada-alemtuzumab-obmedzenia-indikacii-dalsie-kontraindikacie-a-opatrenia-na-minimalizaciu-rizika 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-13.-16.1.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/picato-ingenol-mebutat-pozastavenie-rozhodnutia-o-registracii-z-dovodu-rizika-koznych-malignit 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/zmena-notifikovanej-osoby-predlozenie-noveho-certifikatu-pre-zp-v-databaze 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-10.-vydania-europskeho-liekopisu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prechod-do-dalsej-fazy-overovania-bezpecnostnych-prvkov 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/hlasenie-podozreni-na-neziaduce-ucinky-liekov/informacia-o-postupoch-po-prijati-hlasenia-podozrenia-na-neziaduci-ucinok 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xeljanz-tofacitinib-zvysene-riziko-venozneho-tromboembolizmu-a-zvysene-riziko-zavaznych-a-smrtelnych-infekcii 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-32.1 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-10.-13.2.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/zmeny-pri-centralizovanych-liekoch 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medzinarodny-den-zriedkavych-chorob 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mepact-mifamurtid-potencialna-nefunkcnost-alebo-pretekanie-filtra 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-teyla-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-ornibel-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/european-paediatric-formulary 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/pokyny/mimoriadne-opatrenia-pre-klinicke-skusania-v-dosledku-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-statneho-ustavu-pre-kontrolu-lieciv-k-uzivaniu-liekov-s-obsahom-ibuprofenu-v-suvislosti-s-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/odporucenie-statneho-ustavu-pre-kontrolu-lieciv-v-suvislosti-so-samotestami-na-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-9.-12.3.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zastavenie-pouzivania-ulipristalacetatu-5-mg-esmya-na-liecbu-myomov-maternice-pocas-prehodnocovania-rizika-poskodenia-pecene 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vyzva-na-obmedzenie-vydaja-a-predaja-liekov 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-esmya-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/distribucia/opatrenie-mz-sr-tykajuce-sa-lieku-plaquenil 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/covid-19-statny-ustav-pre-kontrolu-lieciv-varuje-pred-nakupom-falsovanych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/usmernenie-ema-a-sukl-k-liecbe-hypertenzie-a-ochoreni-srdca-alebo-obliciek-liekmi-ovplyvnujucimi-raas-system-pocas-pandemie-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/lieky-apripravky-ex-tempore-vyuzitelne-pri-liecbe-deti-sdiagnozou-covid-19-aktualizacia 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5324 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/covid-19-potencialne-lieky-a-vakciny 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/prehlady-prezentacie-a-publikacie/sarap-2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/informacie-k-priprave-ex-tempore-pre-deti-s-diagnozou-covid-19-aktualizacia 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2019 2020-04-09 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vyrocna-sprava-za-rok-2019 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/obmedzenia-pri-pouzivani-cyproteronacetatu-z-dovodu-rizika-meningiomu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/usmernenia-k-alternativnemu-postupu-predpisovania-liekov-na-lekarsky-predpis-so-sikmym-modrym-pruhom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizovane-odporucenie-statneho-ustavu-pre-kontrolu-lieciv-ksamotestom-na-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/posobnost/vykon-inspekcii-pocas-pandemie-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/prevod-registracie-humanneho-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-14.-17.4.2020 2026-03-20 weekly https://www.sukl.sk/sk/inspekcia/postregistracna-kontrola/prerusenia-dodavok-liekov-v-sr/nedostupnost-liekov-v-case-pandemie-covid-19 2022-04-05 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-apeluje-na-nahlasovanie-neziaducich-ucinkov-u-pacientov-s-covid-19.-pomozete-tak-pri-vyskume-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pouzitie-hydroxychlorochinu-plaquenilr-v-suvislosti-s-ochorenim-covid-19-riziko-predlzenia-qt-intervalu-a-liekovych-interakcii 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/depakine-a-depakine-chrono-500-mg-valproat-karta-pre-pacientku-ako-sucast-vonkajsieho-obalu-lieku-a-pripomenutie-programu-prevencie-tehotenstva 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/typy-testov-pouzivanych-pri-diagnostike-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zovudex-125-mg-brivudin-potencialne-fatalna-toxicita-fluoropyrimidinov-v-pripade-podavania-kratko-pred-alebo-sucasne-s-brivudinom-alebo-do-4-tyzdnov-po-ukonceni-liecby-brivudinom 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-55-2020 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/aktualizovany-postup-pri-podavani-ziadosti-o-zrusenie-rozhodnutia-registracie-liekov 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tolperizon-sa-ma-predpisovat-iba-dospelym-pacientom-na-liecbu-spasticity-po-mozgovej-prihode 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/odporucane-opatrenia-k-podavaniu-oxidu-dusneho-ekvimolarnych-zmesi-kyslika-a-oxidu-dusneho-pacientom-s-infekciou-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-11.-14.5.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zrusenie-mimoriadnych-opatreni-statneho-ustavu-pre-kontrolu-lieciv 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/nakladanie-s-odpadmi/priloha-c.-4.-ku-mp-105-2024-oznam-pre-obcanov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/nakladanie-s-odpadmi/priloha-c.-3.-ku-mp-105-2024-prevadzkovy-poriadok-lekarne-pre-miesto-vyhradene-na-zhromazdovanie-nebezpecneho-odpadu-kat.-c.-200131-cytotoxicke-a-cytostaticke-latky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/nakladanie-s-odpadmi/priloha-c.-2.-ku-mp-105-2024-identifikacny-list-nebezpecneho-odpadu-kat-c.-200131 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/nakladanie-s-odpadmi/priloha-c.-1.-ku-mp-105-2024-opatrenia-pre-pripad-havarie-pri-nakladani-s-nebezpecnym-odpadom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-obsahujuce-5-fluorouracil-i.v.-kapecitabin-a-tegafur-vysetrenie-pred-liecbou-na-identifikaciu-pacientov-s-deficienciou-dihydropyrimidindehydrogenazy-dpd-so-zvysenym-rizikom-zavaznej-toxicity 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/edqm-a-europsky-liekopis-podporuje-vyvoj-vakciny-proti-covid-19-aktualizacia 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/mp-110-2026-hlasenie-o-nedostatkoch-v-kvalite-lieku-a-vo-vyrobe-lieku-pre-drzitela-rozhodnutia-o-registracii-lieku-verzia-c.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/lessons-learnt-skusenosti-ziskane-po-detekcii-nitrozoaminov-vliekoch 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/nakladanie-s-odpadmi/mp-105-2024-zneskodnovanie-liekov-nespotrebovanych-fyzickymi-osobami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-bude-mat-novu-vykonnu-riaditelku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-prveho-lieku-na-covid-19-aktualizacia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/suboxone-sublingvalne-tablety-buprenorfin-naloxon-nepresna-informacia-v-braillovom-pisme-na-hu-cz-sk-obale 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieciva-metronidazolum-az-z-urovne-pacientov 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-minirin-spray-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-6.-9.7.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-obsahujuce-depotne-formy-leuprorelinu-potreba-prisneho-dodrziavania-pokynov-na-rekonstituciu-a-podavanie-s-cielom-znizenia-rizika-chyb-pri-manipulacii-ktore-mozu-viest-k-nedostatocnej-ucinnosti-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-8.-11.6.2020 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/ostatne-publikacie/odpovede-na-otazky-obiologickych-liekoch 2026-04-01 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/upozornenie-na-falosne-samotesty-na-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/costi-domperidon-pripomenutie-schvalenej-indikacie-a-kontraindikacii-suvisiacich-so-zavaznymi-kardiovaskularnymi-neziaducimi-ucinkami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/trisenox-oxid-arzenity-riziko-chyb-v-liecbe-v-dosledku-zavadzania-koncentracie-2-mg-ml 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/predlzenie-prechodneho-obdobia-pri-uplatnovani-nariadenia-o-overovani-pravosti-liekov 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/covid-19/aktualizacia-mimoriadnych-opatreni-pre-klinicke-skusania-v-dosledku-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/pokyny/covid-19 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/poplatky 2025-02-04 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/faq-najcastejsie-otazky 2025-02-04 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/pokyny/usmernenia 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/pokyny/metodicke-pokyny 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/pokyny/gcp-skp 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-31.8.-3.9.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-32.3 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5439 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/odporucenie-ema-na-pouzitie-dexametazonu-na-liecbu-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/pozastavenie-registracie-liekov-sobsahom-ranitidinu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/databazy-a-servis/vyhadavanie-liekov-zdravotnickych-pomocok-a-zmien-v-liekovej-databaze/vyhladavanie-v-databaze-klinickych-skusani 2026-04-15 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-hlohovy-caj-z-trhu 2026-04-14 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/sk-as-rms 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/mp-135-2020-metodicky-pokyn-na-podavanie-ziadosti-kde-sr-sukl-vystupuje-ako-referencny-stat-rms 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-28.9.-1.10.2020 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/aktualizacia-narodnej-databazy-intervencnych-klinickych-skusani 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-32.4 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/liekove-rizika-archiv/liekove-riziko-56-2020 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-adrenalin-bradex-z-trhu 2026-04-14 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/cko-faq/testy-na-covid-19-otazky-a-odpovede 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/antigenove-testy-na-plosne-testovanie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fluorchinolony-na-systemove-a-inhalacne-pouzitie-riziko-regurgitacie-insuficiencie-srdcovych-chlopni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/esbriet-pirfenidon-dolezita-aktualizacia-informacii-o-bezpecnosti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medsafetyweek-2020-kazde-hlasenie-sa-pocita 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gilenya-fingolimod-aktualizovane-odporucania-na-minimalizaciu-rizika-liekom-indukovaneho-poskodenia-pecene-dili 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-26.-29.10.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/tecfiderar-dimetylfumarat-aktualizovane-odporucania-vzhladom-na-vyskyt-pripadov-progresivnej-multifokalnej-leukoencefalopatie-pml-u-pacientov-s-miernou-lymfopeniou 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/dodatok-c.-2-ku-kontraktu-uzatvorenom-medzi-mzsr-a-sukl-na-rok-2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/antibioticka-rezistencia-co-mozem-urobit 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/vyvoj-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-prijala-dve-ziadosti-o-podmienecnu-registraciu-vakciny-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-losartan-zentiva-z-trhu 2026-04-14 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/spustenie-modulu-actors-eudamed 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-23.-26.11.2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/gliolan-5-aminolevulinova-kyselina-5-ala-dolezite-informacie-o-tom-co-robit-v-pripade-odlozeneho-chirurgickeho-vykonu-a-informacie-o-fluorescencii-pri-gliomoch-ineho-ako-vysokeho-stupna-malignity 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/podavanie-ziadosti-a-dokumentacie-na-srl 2020-12-09 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/podavanie-ziadosti-a-dokumentacie-na-srl/tlaciva-forms 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/podavanie-ziadosti-a-dokumentacie-na-srl/poplatky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/podavanie-ziadosti-a-dokumentacie-na-srl/podavanie-ziadosti 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/podavanie-ziadosti-a-dokumentacie-na-srl/podavanie-dokumentacie 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/dodatok-c.-3-ku-kontraktu-uzatvorenom-medzi-mzsr-a-sukl-na-rok-2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/posunuty-harmonogram-pre-registraciu-prvej-vakciny-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/pokyny/metodicke-pokyny 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/metamizol-riziko-liekom-indukovaneho-poskodenia-pecene 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-zerbaxa-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-acnatac-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/posunuty-harmonogram-pre-registraciu-druhej-vakciny-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/mp-137-2020-poziadavky-na-dokumenty-spravnej-vyrobnej-praxe-pri-predkladani-ziadosti-o-povolenie-klinickeho-skusania 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-prvej-vakciny-proti-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/pharmacovigilance/vaccines/vaccines-against-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/ako-hlasit-podozrenia-na-neziaduce-ucinky-v-suvislosti-s-ockovanim 2026-04-15 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-cinacalcet-teva-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/comirnaty-dokumenty-1-1 2026-04-15 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/mp-114-2022-postup-pri-podavani-zmien-dodatkov-a-oznamenia-o-ukonceni-klinickeho-skusania-liekov 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zerbaxa-ceftolozan-tazobaktam-1-g-05-g-prasok-na-infuzny-koncentrat-celosvetove-stiahnutie-lieku-z-trhu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-druhej-vakciny-proti-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/spikevax-povodne-covid-19-vaccine-moderna-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vakcina-comirnaty-sest-davok-v-jednej-liekovke 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-prijala-tretiu-ziadost-o-podmienecnu-registraciu-vakciny-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/overovanie-bezpecnostnych-prvkov-liekov-po-9.2.2021 2026-03-20 weekly https://www.sukl.sk/o-nas/databazy-a-servis/ine-zoznamy/uzatvorenie-pokladne-sukl-od-14.1.2021 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/liek-alebo-vyzivovy-doplnok 2026-03-20 weekly https://www.sukl.sk/sk/registracia-humannych-liekov/mam-moj-produkt-registrovat-ako-liek/covid-19-prioritne-posudzovanie-registracii-a-klinickych-skusani 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5524 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-tretej-vakciny-proti-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-11.-14.1.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/vaxzevria-povodne-covid-19-vaccine-astrazeneca-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-analyza-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/delegovane-nariadenie-komisie-eu-2020-1737-zo-14.-jula-2020-ktorym-sa-meni-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-o-prekurzoroch-drog-a-nariadenie-rady-es-c.-111-2005-pokial-ide-o-zaradenie-urcitych-drogo 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/elektronizacia 2021-02-09 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/elektronizacia/prijem-ziadosti-na-srl 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/predkladanie-ziadosti-na-srl 2026-04-15 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/vyhodnotenie-kontraktu-za-rok-2020-medzi-mz-sr-a-sukl 2026-03-20 weekly https://www.sukl.sk/o-nas/databazy-a-servis/ine-zoznamy/zmena-pre-dorucovanie-pisomnosti-a-zasielok-do-podatelne-sukl-od-12.2.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/mp-138-2021-pre-ziskanie-sublicencnej-zmluvy-na-internetovy-vydaj-liekov 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-olfen-teva-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-prijala-ziadost-o-podmienecnu-registraciu-vakciny-covid-19-vaccine-janssen 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/uloha-sukl-u-pri-posudeni-vakciny-sputnik-v 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-8.-11.2.2021 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5547 2026-03-12 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-pouzitie-kombinacie-monoklonalnych-protilatok-pri-liecbe-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/nebezpecenstvo-atmosfer-obohatenych-kyslikom-v-prostredi-zdravotnickych-zariadeni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/februar-2021-mesacna-analyza-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vakcina-sputnik-v-v-priebeznom-hodnoteni-europskej-liekovej-agentury 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-33.1 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/preskumanie-sarze-vakciny-od-astrazeneca 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-vakciny-covid-19-vaccine-janssen 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zolgensma-onasemnogen-abeparvovek-riziko-trombotickej-mikroangiopatie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/jcovden-povodne-covid-19-vaccine-janssen-dokumenty 2026-04-15 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5564 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xeljanzr-tofacitinib-uvodne-vysledky-z-klinickeho-skusania-ohladom-zvyseneho-rizika-vyskytu-zavaznych-neziaducich-kardiovaskularnych-udalosti-a-malignit-okrem-nmsc-pri-uzivani-tofaci 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-8.-11.3.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-agomelatin-teva-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/covid-19-vaccine-astrazeneca-riziko-trombocytopenie-a-poruch-koagulacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zmena-nazvu-vakciny-od-astrazeneca-na-vaxzevria 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.4.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/marec-2021-mesacna-analyza-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-9.-4.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-33.2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vaxzevria-covid-19-vaccine-astrazeneca-suvislost-medzi-vakcinou-a-vyskytom-trombozy-v-kombinacii-s-trombocytopeniou 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-6.-9.4.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-15.-4.-2021 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/pravidelny-audit-potvrdil-uspesnu-certifikaciu-sukl-v-sieti-omcl-laboratorii-1 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-22.-4.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/covid-19-vaccine-janssen-suvislost-medzi-ockovacou-latkou-a-vyskytom-trombozy-v-kombinacii-s-trombocytopeniou 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-cefimed-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-29.-4.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/april-2021-mesacna-analyza-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-7.-5.-2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-telviran-z-trhu 2026-04-14 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/dodatok-c.-1-ku-kontraktu-uzatvorenom-medzi-mzsr-a-sukl-na-rok-2021 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2020 2021-05-13 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vyrocna-sprava-za-rok-2020 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-13.-5.-2021 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/europska-komisia-udi-helpdesk 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-20.-5.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/registrovane-lieky-s-obsahom-drogoveho-prekurzora 2021-05-21 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-28.-5.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-pouzivanie-vakciny-comirnaty-u-dospievajucich-od-12-do-15-rokov 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/cko-faq/otazky-a-odpovede-k-registracii-v-databaze-eudamed-a-ucinnosti-nariadenia-ep-a-reu-2017745-mdr 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vaxzevria-covid-19-vaccine-astrazeneca-riziko-trombozy-v-kombinacii-s-trombocytopeniou-aktualizovana-informacia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-4.-6.-2021 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/slovnik-farmaceutickych-pojmov 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/maj-2021-mesacna-analyza-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-10.-6.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/venclyxto-venetoklax-filmom-obalene-tablety-aktualizovane-odporucania-tykajuce-sa-syndromu-z-rozpadu-nadoru-tls-u-pacientov-s-chronickou-lymfocytovou-leukemiou-cll 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/elektronizacia/vydavanie-a-dorucovanie-uradneho-dokumentu-sekciou-registracie-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-17.-6.-2021 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-7.-10.6.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zmena-nazvu-vakciny-od-moderna-na-spikevax 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vaxzevria-covid-19-vaccine-astrazeneca-kontraindikacia-u-osob-s-predchadzajucim-syndromom-kapilarneho-uniku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-24.-6.-2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-uniclophen-01-z-trhu-2 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.-7.-2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-betalmic-05-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xeljanzr-tofacitinib-zvysene-riziko-zavaznych-neziaducich-kardiovaskularnych-udalosti-a-malignit-pri-liecbe-tofacitinibom-v-porovnani-s-inhibitormi-tnf-alfa 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-12.-7.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/jun-2021-mesacna-analyza-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/comirnaty-a-spikevax-mozna-suvislost-s-velmi-zriedkavymi-pripadmi-myokarditidy-a-perikarditidy 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-uniclophen-01-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/champix-vareniklin-stahovanie-sarzi-z-dovodu-pritomnosti-necistoty-n-nitrozo-vareniklinu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-15.-7.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-33.3 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/covid-19-vaccine-janssen-kontraindikacia-u-osob-s-predchadzajucim-syndromom-kapilarneho-presakovania-a-aktualizacia-tykajuca-sa-syndromu-trombozy-s-trombocytopeniou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mrna-ockovacie-latky-proti-ochoreniu-covid-19-comirnaty-a-spikevax-riziko-myokarditidy-a-perikarditidy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-zo-stretnutia-vyboru-pre-hodnotenie-rizik-liekov-prac-5.-8.7.2021 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5652 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-irbesartan-zentiva-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-irbesartan-hydrochlorothiazide-zentiva-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-29.-7.-2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-uniclophen-01-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-5.8.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-12.-8.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-19.-8.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-26.-8.-2021 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/zdravotnicke-pomocky-elektronicke-podavanie-ziadosti-cez-system-evar 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-mitomycin-medac-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2021-modul-1-a-2 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5671 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/roactemra-tocilizumab-docasny-nedostatok-dodavok-lieku-roactemra-20-mg-ml-infuzny-koncentrat-i.v.-forma-a-odporucania-tykajuce-sa-zvladnutia-mozneho-rizika-vzplanutia-ochorenia-u-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-9.-9.-2021 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/odporucanie-v-ramci-zabezpecenia-zdravotnickych-pomocok-pri-preventivnych-opatreniach-covid-19-oxymetre-a-bezkontaktne-teplomery 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-16.-9.-2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-unilat-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-pfizer-biontech-koncentrat-na-injekcnu-disperziu-30mg-davka 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-30.-9.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/champix-vareniklin-stahovanie-sarzi-z-dovodu-pritomnosti-necistoty-n-nitrozo-vareniklinu-ktory-je-nad-akceptovatelnym-limitom-prijmu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-27.-30.9.2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-losartan-zentiva-z-trhu-aktualizacia 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-lozap-h-z-trhu-aktualizacia 2026-04-14 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznamenie-pre-sponzorov-klinickych-skusani 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-7.-10.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/covid-19-vaccine-janssen-riziko-imunitne-podmienenej-tromocytopenie-itp-a-venozneho-tromboembolizmu-vte 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vaxzevria-covid-19-vaccine-astrazeneca-riziko-trombocytopenie-vratane-imunitne-podmienenej-trombocytopenie-s-pridruzenym-krvacanim-alebo-bez-neho 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zaznam-z-tematickeho-kurzu-sarap-7.-8.10.2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-14.-10.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-33.4 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/cko-faq/vseobecne-otazky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-21.-10-2021 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznamenie-o-zverejneni-informacneho-bulletinu-k-dolezitym-udalostiam-v-suvislosti-s-ctis 2026-04-08 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznam-o-zverejneni-novych-tlaciv-pre-registraciu-oznamenie-vyrobcu-azp 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/elektronicke-ziadosti/postup-pre-vyplnenie-elektronickej-ziadosti-oznamenie-vyrobcu-a-zp 2021-10-27 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/elektronicke-ziadosti/instrukcie-k-vyplnaniu-jednotlivych-riadkov-elektronickeho-oznamenia-vyrobcu-a-zp 2021-10-27 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-28.-10.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/oznamenie-zdravotnickej-pomocky-zp-od-zahranicneho-vyrobcu-ec-rep/oznamenie-o-ivd-zp 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-urapidil-stragen-z-trhu 2026-04-14 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/korigendum-k-delegovanemu-nariadeniu-komisie-eu-2020-1737-zo-14.-jula-2020-ktorym-sa-meni-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-a-nariadenie-rady-es-c.-111-2005-pokial-ide-o-zaradenie-urcitych-drogovych 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/doreta-sr-75mg-650mg-tablety-s-predlzenym-uvolnovanim-uprava-pokynov-na-liecbu-predavkovania-tramadolom-paracetamolom-s-predlzenym-uvolnovanim 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/doreta-sr-75mg-650mg-tablety-s-predlzenym-uvolnovanim-dolezite-informacie-o-riziku-predavkovania-a-tazkeho-poskodenia-pecene-po-predavkovani 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-diabetan-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-4.-11.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/beovu-brolucizumab-aktualizacia-odporucani-na-minimalizaciu-znameho-rizika-vnutroocneho-zapalu-vratane-retinalnej-vaskulitidy-a-alebo-retinalnej-vaskularnej-okluzie 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-v-pripad-uhrady-spravnych-sadzobnikovych-poplatkov-na-nespravny-ucet 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-monoklonalnych-protilatok-na-liecbu-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-11.-11.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-18.-11.-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/regkirona-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/ronapreve-dokumenty 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznam-o-spracovani-ziadosti-do-kategorizacie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-vakcinu-comirnaty-pre-deti-od-5-11-rokov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/oznam-v-suvislosti-s-pandemiou-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-25.-11.-2021 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-losartan-stada-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-losartan-hydrochlorothiazid-stada-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/nakladanie-s-odpadmi/informacie-ohladom-likvidacie-samotestov-na-sars-cov-2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/oznam-o-vykonavani-inspekcii-v-suvislosti-s-pandemickou-situaciou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-2.-12.-2021 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-zadavatelov-klinickych-skusani-o-zverejneni-prirucky-guidebook-principles-for-sponsor-organisation-modelling-for-ctis 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-9.-12.-2021 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznamenie-o-zverejneni-informacneho-bulletinu-ctis-highlights 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/registracia-centier-klinickeho-skusania-v-systeme-ctis-clinical-trials-information-system 2026-04-08 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5750 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-imbruvica-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/vakciny-a-lieky-proti-covid-19-prehlad 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-podmienecnu-registraciu-vakciny-nuvaxovid 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/klinicke-skusania-na-slovensku-po-31.-januari-2022 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/nariadenie-europskeho-parlamentu-a-rady-eu-c.-536-2014 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/roactemra-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/xevudy-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/nuvaxovid-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-5.-1.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mitomycin-medac-dolezita-informacia-o-liekoch-spolocnosti-medac-gmbh-obsahujucich-liecivo-mitomycin-obmedzenia-pre-intravenozne-pouzitie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-13.-1.-2022 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznam-o-aktualizacii-tlaciva-navrh-na-vyuctovanie-podla-sadzobnika-vykonov-a-sluzieb 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-20.-1.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-34.1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/kineret-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/paxlovid-odporucanie-ema-na-podmienecnu-registraciu-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/bcg-medac-bacillus-calmette-guerin-zavedenie-pohotovostnej-karty-pacienta 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-27.-1.-2022 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/klinicke-skusania-na-slovensku-po-31.-januari-2022-zhrnutie-informacneho-dna 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dinoproston-minimalizacia-rizika-zavaznych-komplikacii-v-dosledku-hyperstimulacie-maternice-a-ruptury-maternice 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznamenie-o-aktualizacii-sadzobnika-vykonov-a-sluzieb-suvisiacich-s-ucinnostou-nariadenia-europskeho-parlamentu-a-rady-eu-c.-536-2014-k-31.1.2022 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/spustenie-europskeho-informacneho-systemu-pre-klinicke-skusania-clinical-trials-information-system-ctis-od-31.-januara-2022 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-cholagol-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-ma-noveho-riaditela 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/paxlovid-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-3.-2.-2022 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-pfizer-biontech-koncentrat-na-injekcnu-disperziu-10mg-davka 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mavenclad-kladribin-riziko-zavazneho-poskodenia-pecene-a-nove-odporucania-tykajuce-sa-monitorovania-funkcie-pecene 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=5796 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-liekov-everio-z-trhu 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-7.-10.2.2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/eylea-40mg-ml-roztok-afliberceptu-na-intravitrealnu-injekciu-vyssie-riziko-zvysenia-vnutroocneho-tlaku-s-naplnenou-injekcnou-striekackou 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/inomax-oxid-dusnaty-tazkosti-pri-zatvarani-ventilov-na-flasi-po-pouziti-bezpecnostne-opatrenia-pri-odpajani-flias-z-regulatorov-tlaku 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/vyhodnotenie-kontraktu-za-rok-2021-medzi-mz-sr-a-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-17.-2.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/iberogast-peroralny-roztok-riziko-liekom-indukovaneho-poskodenia-pecene 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-24.-2.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/ministerstvo-zdravotnictva-statny-ustav-pre-kontrolu-lieciv-a-slovenska-lekarnicka-komora-vyzyvaju-jednotlivcov-aby-na-hranice-s-ukrajinou-neposielali-lieky 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/dodatok-c.-2-ku-kontraktu-uzatvorenom-medzi-mzsr-a-sukl-na-rok-2021 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-3.-3.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-neodporuca-zasobovanie-sa-liekmi-s-obsahom-jodu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/infliximab-remicade-infectra-remsima-a-zessly-podavanie-zivych-ockovacich-latok-dojcatam-vystavenym-infliximabu-in-utero-alebo-pocas-dojcenia 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-pouzivatelov-informacneho-systemu-pre-klinicke-skusania-ctis-dva-pripravovane-webinare-organizovane-europskou-liekovou-agenturou 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-vigantol-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-10.-3.-2022 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/usmernenie-statneho-ustavu-pre-kontrolu-lieciv-k-preradeniu-ukrajinskych-ucastnikov-klinickeho-skusania-z-centier-na-ukrajine-do-centier-v-slovenskej-republike 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-liekov-accuzide-z-trhu 2026-04-14 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/oznamenie-o-pozastaveni-ce-oznacenia 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2021 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2021/sarap-2021-modul-1-a-modul-2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-17.-3.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-24.-3.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/veklury-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/evusheld-dokumenty 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-spikevax-moderna 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/tyzdenna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.-4.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/odporucenie-europskej-liekovej-agentury-ema-a-europskeho-centra-pre-prevenciu-a-kontrolu-chorob-ecdc-ohladom-stvrtej-davky-mrna-vakcin-proti-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-4.-7.4.2022 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/vydavanie-certifikatov-volneho-predaja-pre-zdravotnicke-pomocky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2022-modul-1-novinky-v-oblasti-registracie-liekov-a-postregistracna-kontrola-liekov-1 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-hromadne-pripravovaneho-humanneho-lieku-jodid-draselny-cps-6x65-mg-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-liekov-accupro-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-vigantol-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-34.2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-2.-5.-2022 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/oznamenie-o-vymene-inzulinovej-pumpy-minimed-600-od-spolocnosti-medtronic 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-na-12-mesiacov-pfizer-biontech-vsetky-liekove-formy 2026-04-15 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-isoprinosine-50-mg-ml-sirup-z-trhu 2026-04-14 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/update-of-application-for-transfer-of-a-marketing-authorisation-for-human-medicinal-product 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamovacia-povinnost-ivd-zp-po-26.-5.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/anagrelid-riziko-trombozy-vratane-ischemickej-cievnej-mozgovej-prihody-po-nahlom-preruseni-liecby 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/oznamenie-zdravotnickej-pomocky-zp-od-zahranicneho-vyrobcu-ec-rep 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/hlasenie-zmien-k-oznameniam-a-registraciam 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/elektronicke-ziadosti 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/registracia-zdravotnickej-pomocky-zp-od-vyrobcu-ec-rep-so-sidlom-v-sr 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/registracia-distributora-zdravotnickych-pomocok-a-in-vitro-zdravotnickych-pomocok 2026-04-08 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2021 2022-05-26 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vyhodnotenie-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2021 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/navrh-na-vyuctovanie-podla-sadzobnika-vykonov-a-sluzieb-platny-od-1.3.2023 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/ziadost-o-vratanie-spravneho-poplatku-nove 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/es-vyhlasenie-o-zhode-vzor-nove 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/priloha-k-formularu-pri-zmene-znenia-kodu-zp-od-1.3.2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/vzor-splnomocnenie-od-vyrobcu-nove 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/priloha-k-formularu-zakladna-od-1.3.2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/formular-na-registraciu-oznamenie-zp-ivd-zp-od-1.3.2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/priloha-k-formularu-pre-zp-s-roznym-opisom-a-ucelom-urcenia-od-1.3.2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/sprievodny-list-k-dokumentacii-od-1.3.2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/ziadost-o-vydanie-certifikatu-volneho-predaja-application-for-issuance-of-certificate-of-free-sale 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.-6.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2022-modul-1-novinky-v-oblasti-registracie-liekov-a-postregistracna-kontrola-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/registracia-distributora-zdravotnickych-pomocok-a-in-vitro-zdravotnickych-pomocok/obmedzenie-platnosti-registracie-distributora-na-5-rokov 2022-06-09 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/obmedzenie-platnosti-registracie-distributora-zp-na-5-rokov-s-ucinnostou-od-26.5.2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ocalivar-kyselina-obeticholova-nova-kontraindikacia-liecby-primarnej-biliarnej-cholangitidy-pbc-u-pacientov-s-dekompenzovanou-cirhozou-pecene-alebo-dekompenzaciou-pecene-v-anamneze 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/usmernenie-o-predkladani-navrhov-obalov-liekov-mock-up 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/defitelio-defibrotid-nepouzivajte-na-profylaxiu-venookluzivneho-ochorenia-po-transplantacii-hematopoetickych-kmenovych-buniek 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/informacia-pre-drzitelov-povoleni-na-zaobchadzanie-s-urcenymi-latkami-kategorie-1-a-drzitelov-registracii-na-zaobchadzanie-s-urcenymi-latkami-kategorie-2-a-3-ktori-obchoduju-s-rf 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/upravena-verzia-vakciny-comirnaty-v-priebeznom-hodnoteni-europskej-liekovej-agentury 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dexmedetomidin-zvysene-riziko-umrtnosti-u-pacientov-na-jednotke-intenzivnej-starostlivosti-jis-65-rokov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-ema-odporucila-pouzivanie-vakciny-nuvaxovid-u-dospievajucich-od-12-do-17-rokov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-vakciny-covid-19-vaccine-valneva 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/upravena-verzia-vakciny-spikevax-v-priebeznom-hodnoteni-europskej-liekovej-agentury 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-angusta-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/ziadost-o-spatvzatie-podania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/preskumanie-vakciny-imvanex-na-prevenciu-opicich-kiahni 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznam-o-aktualizacii-tlaciva-navrh-na-vyuctovanie-podla-sadzobnika-vykonov-a-sluzieb-platny-od-1.7.2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.-7.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/valneva-dokumenty 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznam-o-nevracani-poplatkov-podla-sadzobnika-sukl 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-amiodaron-hameln-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-34.3 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/schvalenie-vakciny-imvanex-na-prevenciu-opicich-kiahni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizovane-otazky-a-odpovede-k-druhej-posilnujucej-davke-proti-covid-19-a-upravenym-vakcinam 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-elenium-z-trhu-1 2026-04-14 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/spolocny-dokument-na-predkladanie-odpovedi-applicants-response-template 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.-8.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/zmena-uradnych-hodin-podatelne-v-obdobi-od-15.-8.-do-26.-8.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-statneho-ustavu-pre-kontrolu-lieciv-k-nedostupnosti-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-prijala-ziadost-o-podmienecnu-registraciu-vakciny-skycovion-proti-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-na-15-mesiacov-koncentrat-na-injekcnu-disperziu-30mg-davka 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-spikevax-na-12-mesiacov 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2022-modul-2-farmakovigilancna-prax.-inspekcia.-legislativa-1 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-haloperidol-richter-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-europskej-unii-boli-schvalene-prve-upravene-vakciny-proti-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-2.9.-2022 2026-03-20 weekly https://www.sukl.sk/o-nas/o-sukl/misia-vizia-a-strategicke-ciele 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/comirnaty-original-omicron-ba.1-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/misia-vizia-a-strategicke-ciele-statneho-ustavu-pre-kontrolu-lieciv-na-roky-2022-2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/spikevax-bivalent-original-omicron-ba.1-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/comirnaty-original-omicron-ba.4-5-dokumenty 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/vynimky-z-postupov-posudzovania-zhody-podla-clanku-59-mdr-a-clanku-54-ivdr 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/nove-odporucania-pre-lieky-obsahujuce-nesteroidne-antiflogistika-nsaid-na-systemove-pouzitie-pocas-tehotenstva 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-3.-10.-2022 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-paxeladine-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-34.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/vakciny-comirnaty-aj-spikevax-pre-deti-od-6-mesiacov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2022-modul-2-farmakovigilancna-prax.-inspekcia.-legislativa 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/v-dnoch-31.10.2022-a-18.11.2022-bude-podatelna-sukl-aklientske-centrum-zatvorene 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/delegovane-nariadenie-komisie-eu-2022-1518-z-29.-marca-2022-ktorym-sa-meni-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-a-nariadenie-rady-es-c.-111-2005 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/zoznam-prijatych-ziadosti-o-novu-registraciu 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-2.-11.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/spikevax-bivalent-original-omicron-ba.4-5-dokumenty 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/imbruvica-ibrutinib-nove-opatrenia-na-minimalizaciu-rizika-vratane-odporucani-na-upravu-davky-z-dovodu-zvyseneho-rizika-zavaznych-srdcovych-prihod 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/xalkori-krizotinib-poruchy-zraku-vratane-rizika-zavaznej-straty-zraku-potreba-monitorovania-u-pediatrickych-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/v-dnoch-27.-12.-2022-az-5.-1.-2023-budu-podatelna-sukl-a-klientske-centrum-zatvorene.-zmena-vo-vybavovani-ziadosti-o-inspekcie-ziadosti-do-kategorizacie-zp 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/media/news/from-december-27-2022-to-january-5-2023-the-post-registry-office-and-the-client-center-of-sidc-will-be-temporarily-closed 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/zoznam-distributorov-zdravotnickych-pomocok 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/europska-liekova-agentura-odporucila-registraciu-vakciny-proti-covid-19-vidprevtyn-beta 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/chlormadinon-acetat-a-nomegestrol-acetat-opatrenia-na-minimalizaciu-rizika-meningeomu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/spravne-davkovanie-bivalentnych-posilnovacich-vakcin-spikevax 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/vidprevtyn-beta-dokumenty 2026-04-15 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-zadavatelov-a-ziadatelov-klinickych-skusani-v-suvislosti-so-zvysenym-poctom-podanych-inicialnych-klinickych-skusani-pri-ktorych-sa-uplatnuje-smernica-2001-20-es 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/posledny-termin-na-podanie-ziadosti-o-klinicke-skusania-podla-smernice-smernice-2001-20-es-je-30.-januar-2023 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-stoptussin-sirup-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-1.-12.-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/terlipresin-ever-pharma-terlipresin-zavazne-az-fatalne-respiracne-zlyhanie-a-sepsa-septicky-sok-u-pacientov-s-hepatorenalnym-syndromom-1.-typu-hrs-1.-typu 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-neurol-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-lekarnach-mozu-chybat-niektore-druhy-liekov-ake-su-moznosti-pacientov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/sekcia-registracie-oznam-o-zmene-prijimania-ziadosti-od-1.1.2023 2026-04-15 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/submission-of-applications 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/procedure-for-submitting-registration-documentation-to-sidc 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/receiving-of-applications-for-srl 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/registration-change-of-application-submitting-procedure-from-1.1.2023 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/caprelsa-vandetanib-obmedzenie-indikacie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-na-18-mesiacov-pfizer-biontech 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/sekcia-zdravotnickych-pomocok-elektronicka-komunikacia-prostrednictvom-upvs-slovensko.sk-upozornenie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/aktuality/oznam-pre-drzitelov-registracie-humannych-liekov-registrovanych-v-slovenskej-republike 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6061 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/kontakt/telefonne-cisla/kontrolne-laboratorium-1-kvetna-11-825-08-bratislava 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/kontakt/telefonne-cisla/kontrolne-laboratorium-2-stummerova-4-955-01-topolcany 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/kontakt/telefonne-cisla/kontrolne-laboratorium-3-studentska-28-960-01-zvolen 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/kontakt/telefonne-cisla/kontrolne-laboratorium-4-boricka-cesta-45-010-01-zilina 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/o-nas/kontakt/telefonne-cisla/kontrolne-laboratorium-5-rastislavova-43-041-90-kosice 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mesacna-statistika-hlaseni-podozreni-na-neziaduce-ucinky-vakcin-na-prevenciu-covid-19-13.-1.-2023 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-na-18-mesiacov-pfizer-biontech-koncentrat-na-injekcnu-disperziu-30mg-davka 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/l-thyroxin-berlin-chemie-levotyroxin-tablety-s-novym-zlozenim-pomocnych-latok-sledovanie-pacientov-ktori-prechadzaju-na-tieto-tablety 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-diprophos-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zmena-liecby-u-pacientov-uzivajucich-norditropin-nordiflex-somatropin-ludsky-rastovy-hormon-na-ine-lieky-v-dosledku-nedostupnosti-lieku-norditropin-nordiflex 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-fraxiparine-9-500-iu-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stiahnutie-lieku-fraxiparine-9-500-iu-z-trhu 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/rozbieha-sa-verejna-diskusia-o-novej-platforme-pre-viacere-zainteresovane-strany-na-zlepsenie-klinickych-skusani-v-europskej-unii 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zolgensma-onasemnogen-abeparvovek-fatalne-pripady-akutneho-zlyhania-pecene 2026-03-20 weekly https://www.sukl.sk/sk/drogove-prekurzory/legislativa/delegovane-nariadenie-komisie-eu-2023-196-z-25.-novembra-2022-ktorym-sa-meni-nariadenie-europskeho-parlamentu-a-rady-es-c.-273-2004-a-nariadenie-rady-es-c.-111-2005 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-na-zmenu-navrhu-na-vyuctovanie-sekcie-zp-na-zaklade-noveho-sadzobnika-sukl-platneho-od-1.3.2023 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/postregistracne-procesy/oznamenie-podla-55-5-zakona-362-2011-z.z 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6098 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/oznam-o-ucinnosti-11.-vydania-europskeho-liekopisu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-35.1 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2023 2026-04-09 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/zdravotnicke-pomocky-na-ktore-bol-v-inom-clenskom-state-aplikovany-postup-podla-clanku-97-nariadenia-2017-745-o-zdravotnickych-pomockach-mdr 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-phacebonate-50-mg-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cibinqo-abrocitinib-jyseleca-filgotinib-olumiant-baricitinib-rinvoq-upadacitinib-a-xeljanz-tofacitinib-aktualizovane-odporucania-na-minimalizaciu-rizik-pri-pouzivani-inhibitorov-jaki 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-v-roku-2022 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/zmena-nariadeni-ep-a-rady-c.2017-745-o-zdravotnickych-pomockach-a-c.-2017-746-o-diagnostickych-zdravotnickych-pomockach-in-vitro 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2023-modul-1-aktuality-v-oblasti-regulacie-zdravotnickych-pomocok.-legislativne-prostredie-1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/zoznam-pozadovanej-dokumentacie-pri-vykone-priebeznej-inspekcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/bimervax-dokumenty 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/dostupnost-liekov 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-35.2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/simulect-basiliximab-nepouzivajte-ampulky-rozpustadla-voda-na-injekcie-wfi-ktore-su-sucastou-balenia-lieku-simulect-10-mg-a-20-mg 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/doplnujuce-informacie-k-nariadeniu-ep-a-rady-c.-2023-607-z-15.-marca-2023 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6134 2026-04-14 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/usmernenie-k-vyznamnym-zmenam-v-suvislosti-s-prechodnym-ustanovenim-podla-clanku-120-ods.-3-nariadenia-mdr-naposledy-zmeneneho-nariadenim-eu-2023-607-z-15.3.2023 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pazenir-paklitaxel-vo-forme-nanocastic-viazanych-na-albumin-docasny-vypadok-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/menopur-nedostatok-dodavok-lieku-z-dovodu-chyby-v-kvalite 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/osvetovy-projekt 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/fluorchinolonove-antibiotika-pripomenutie-opatreni-na-znizeniu-dlhotrvajucich-invalidizujucich-alebo-potencialne-ireverzibilnych-vedlajsich-ucinkov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medzinarodny-den-klinickych-skusani 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prebehol-uspesny-follow-up-audit 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-potvrdil-nelegalny-reexport-liekov-zo-slovenska-v-hodnote-viac-ako-styri-miliony-eur 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-ecdc-ema-k-zmenam-vzlozeni-vakcin-na-covid-19 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/aktuality/oznam-o-inspekciach-v-bratislavskom-kraji 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/fluorchinolonove-antibiotika-na-systemove-a-inhalacne-pouzitie-pripomenutie-obmedzeni-pouzivania 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamy-a-informacie-o-nehodach-zp/nezobrazovanie-platnosti-ce-certifikatov-vo-vyhladavacej-databaze-zdravotnickych-pomocok-v-suvislosti-s-nariadenim-eu-2023-607 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/nezobrazovanie-platnosti-ce-certifikatov-vo-vyhladavacej-databaze-zdravotnickych-pomocok-v-suvislosti-s-nariadenim-eu-2023-607 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/experti-zo-sukl-prednasali-ziakom-zakladnych-a-strednych-skol-o-rizikach-falsovanych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2023-modul-1-aktuality-v-oblasti-regulacie-zdravotnickych-pomocok.-legislativne-prostredie 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6164 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-a-sukl-v-prahe-temou-cislo-jeden-bol-nelegalny-reexport-ale-aj-nedostupnost-a-registracia-liekov 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/memorandum-o-spolupraci-s-faf-uk-2023 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2022 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-35.3 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-luxfen-2-mg-ml 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stiahnutie-lieku-luxfen-2-mg-ml-aj-z-urovne-pacienta 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-sabril-tbl-flm-100x500-mg-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/voxzogo-vozoritid-nova-ihla-a-injekcna-striekacka-v-baleni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-sukl-potvrdil-nelegalny-reexport-liekov-v-dalsich-lekarnach 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/hlasenie-podozreni-na-neziaduce-ucinky-liekov/co-je-neziaduci-ucinok-alebo-vedlajsi-ucinok-lieku 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-liekov-amikacin-b.-braun-5-mg-ml-gentamicin-b.-braun-3-mg-ml-infuzny-roztok-ibuprofen-b.-braun-400-mg-ibuprofen-b.-braun-600-mg-a-metronidazol-b.-braun-5-mg-ml-z-trhu 2026-04-14 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6182 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/mp-105-zneskodnovanie-liekov-nespotrebovanych-fyzickymi-osobami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/priloha-c.-1.-ku-mp-105-2024-opatrenia-pre-pripad-havarie-pri-nakladani-s-nebezpecnym-odpadom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/priloha-c.-2.-ku-mp-105-2024-identifikacny-list-nebezpecneho-odpadu-kat-c.-200131 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/priloha-c.-3.-ku-mp-105-2024-prevadzkovy-poriadok-lekarne-pre-miesto-vyhradene-na-zhromazdovanie-nebezpecneho-odpadu-kat.-c.-200131-cytotoxicke-a-cytostaticke-latky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/priloha-c.-4-ku-mp-105-2024-zaobchadzanie-s-nespotrebovanymi-liekmi 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/pridelovanie-slotov-slots-assignment 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/novela-zakona-o-liekoch-a-zdravotnickych-pomockach-a-o-zmene-a-doplneni-niektorych-zakonov-362-2011-z.-z.-casova-verzia-platna-od-1.8.2023 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/vydavanie-certifikatov-volneho-predaja-fsc-od-1.8.2023-na-zaklade-novely-zakona-362-2011-z.-z.-zakon-293-2023-z.-z 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/simponi-zmeny-v-navode-na-pouzitie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/metodicky-pokyn-140-2021-na-predkladanie-navrhu-obalu-lieku-mock-up 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/oznamenie-pre-obcanov-o-potrebe-racionalizacie-v-zasobovani-sa-liekmi-a-zaobchadzani-s-liekovym-odpadom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/mitomycin-medac-zrusenie-obmedzenia-spojeneho-s-pouzitim-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/advate-a-feiba-25-u-ml-vymena-pomocky-baxject-ii-baxject-ii-hi-flow-na-rekonstituciu-dodavanej-ako-sucast-balenia-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prehodnotenie-udajov-europskou-liekovou-agenturou-v-suvislosti-s-uzivanim-liekov-s-obsahom-valproatu-u-muzov 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/vakciny/oznamy-v-suvislosti-s-vakcinami-na-prevenciu-ochorenia-covid-19/predlzenie-exspiracie-vakciny-comirnaty-na-24-mesiacov-pfizer-biontech 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/predlzenie-exspiracie-vakciny-comirnaty-na-24-mesiacov-pfizer-biontech 2026-04-15 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/spolupraca-s-pacientskymi-organizaciami 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/nove-odporucania-na-obmedzenie-pouzivania-liekov-s-obsahom-topiramatu-v-tehotenstve 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/rozhodnutie-o-rozsireni-vekovej-kategorie-deti-na-bezplatne-ockovanie-proti-rakovine-ktoru-sposobuje-virus-hpv 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/comirnaty-omicron-xbb.1.5 2026-04-15 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/sartany 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/zatvorena-podatelna 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-pre-vyrobcov-splnomocnenych-zastupov-dovozcov-alebo-distributorov-zdravotnickych-pomocok-alebo-diagnostickych-zdravotnickych-pomocok-in-vitro 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6226 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpenos-liekov/vakciny/vakciny-proti-covid-19/spikevax-xbb.1.5 2026-04-15 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2023 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2023/sarap-2023-modul-1-a-modul-2 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-35.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-sukl-informuje-v-pripade-falsovania-lieku-ozempic 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/informacie-o-falsovanych-liekoch/statny-ustav-pre-kontrolu-lieciv-sukl-informuje-v-pripade-falsovania-lieku-ozempic 2023-10-18 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/sukl-vypracoval-tretie-vydanie-slovenskeho-farmaceutickeho-kodexu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/topiramat-nove-obmedzenia-na-zabranenie-expozicie-topiramatu-pocas-tehotenstva 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/integrilin-eptifibatid-ukoncenie-vyroby-integrilinu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-v-ramci-medsafetyweek-nahlasenim-neziaducich-ucinkov-moze-kazdy-prispiet-k-zvyseniu-bezpecnosti-liekov 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-zadavatelov-klinickych-skusani-ohladom-podavania-rocnej-spravy-o-aktualnom-stave-klinickeho-skusania-ktore-sa-vykonava-podla-nariadenia-c.-536-2014 2026-04-08 weekly https://www.sukl.sk/en/inspection/post-authorisation-quality-control/medicine-shortages 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/aktuality/vyzva-pre-drzitelov-registracie-liekov-na-registraciu-kontaktnych-osob-pre-dodavky-a-dostupnost-liekov 2026-03-20 weekly https://www.sukl.sk/en/inspection/post-authorisation-quality-control/parallel-importation-parallel-distribution 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-upozornuje-na-dolezitost-spravneho-uzivania-antibiotik-ako-aj-na-ich-dostupnost-pocas-zimnej-sezony 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-sukl-upozornuje-na-spravny-postup-pri-vydaji-liekov-na-lekarsky-predpis 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-pre-klientov-na-docasne-pozastavenie-podavania-noveho-oznamenia-o-zdravotnickej-pomocke-cez-portal-evar 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/zmena-uradnych-hodin-podatelne-dna-11.12.2023 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-informuje-o-minimalizacii-zavaznych-vedlajsich-ucinkov-pri-liekoch-obsahujucich-pseudoefedrin 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6271 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/prvy-unijny-zoznam-kritickych-liekov 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6273 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/aktualizacia-zobrazovanie-textov-spc-a-pil-pri-liekoch-registrovanych-centralizovanou-procedurou-v-slovenskom-jazyku 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/zmena-uradnych-hodin-podatelne-27.12.-29.12.2023 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/oznam-o-zmene-riaditela-ageneralneho-tajomnika-sukl 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-36.1 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/vybor-prac-odporuca-preventivne-opatrenia-pri-liecbe-muzskych-pacientov-liekmi-ktore-obsahuju-valproat 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/opatrenia-pri-liecbe-muzskych-pacientov-liekmi-ktore-obsahuju-valproat 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/spatvzatie-podania 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/podavanie-ziadosti-cez-upvs 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/podavanie-ziadosti-a-dokumentacie-na-srl/vseobecne-informacie-k-predkladaniu-plnomocenstva-alebo-poverenia 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/general-information-on-the-power-of-attorney-and-letter-of-authorisation-presented-to-sidc-including-faq 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-cinacalcet-heaton-30-mg-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/etopozid-riziko-hypersenzitivnych-reakcii-suvisiacich-s-infuziou-pri-podavani-in-line-filtrom 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pseudoefedrin-riziko-syndromu-posteriornej-reverzibilnej-encefalopatie-pres-a-syndromu-reverzibilnej-cerebralnej-vazokonstrikcie-rcvs 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/potvrdenie-zaverov-vyboru-prac-tykajuce-sa-novych-odporucani-na-minimalizaciu-rizik-neurologickych-syndromov-pre-lieky-obsahujuce-pseudoefedrin 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-s-obsahom-valproatu-nove-opatrenia-tykajuce-sa-potencialneho-rizika-neurovyvinovych-poruch-u-deti-otcov-liecenych-valproatom-pocas-3-mesiacov-pred-pocatim 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/dodavane-balenia-lieku-simulect-10-mg-a-20-mg-obsahuju-iba-injekcnu-liekovku-s-praskom-basiliximab-a-neobsahuju-ampulku-s-vodou-na-injekcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zmena-liecby-u-pacientov-uzivajucich-norditropin-nordiflex 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6305 2026-04-09 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6306 2026-04-09 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6307 2026-04-09 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6308 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-acc-20-mg-ml-peroralny-roztok-pre-deti-a-dospelych 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-sukl-informuje-o-uspesnom-ukonceni-verejneho-obstaravania-na-zabezpecenie-zvozu-liekoveho-odpadu-z-lekarni 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6311 2026-04-09 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/aktualizovane-konferencia-sarap-2024-pozvanka-modul-1-aktuality-v-oblasti-registracie-liekov-a-farmakovigilancie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-8.-11.4.2024 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-metfogamma-500-tbl-flm-120x500-mg-blis.pvc-al-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-informuje-o-stiahnuti-lieku-metfogamma-500-tbl-film-120x500-mg-aj-z-urovne-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stiahnutie-lieku-metfogamma-500-tbl-film-120x500-mg-doplnujuci-pokyn-pre-pacientov-a-lekarnikov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-36.2 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznam-o-aktualizacii-formularov-na-podavanie-ziadosti-o-povolenie-klinickeho-skusania-zp-studie-vykonu-ivd-zp 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6325 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/zmena-uradnych-hodin-podatelne-dna-6.6.2024 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/peroralne-retinoidy-pripomenutie-programu-na-prevenciu-tehotenstva 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekove-agentura-ema-zacala-prehodnocovanie-liekov-obsahujucich-liecivo-metamizol 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/statny-ustav-pre-kontrolu-lieciv-sukl-oslavuje-60-rokov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2024-modul-1-aktuality-v-oblasti-registracie-liekov-a-farmakovigilancie 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-cinacalcet-reddy-30-mg-filmom-obalene-tablety-z-trhu 2026-04-14 weekly https://www.sukl.sk/o-nas/spolupraca/medzinarodna-spolupraca/medzinarodne-projekty 2026-03-12 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6338 2026-04-14 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2024 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/lieky-nie-su-modny-trend-sukl-upozornuje-na-rizika-uzivania-liekov-za-ucelom-chudnutia-do-plaviek 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/prakticke-informacie-k-podavaniu-ziadosti-na-zaklade-nariadenia-ep-a-rady-c.-2023-607-a-s-tym-suvisiace-mozne-predlzenie-lehoty-vybavenia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/upozornenie-pre-vyrobcov-a-velkodistributorov-humannych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/carvykti-kymriah-tecartus-a-yescarta-car-t-bunkove-terapie-cielene-proti-cd-19-alebo-bcma-riziko-sekundarnej-malignity-t-bunkoveho-povodu 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-atofab-10-mg-tvrde-kapsuly-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-36.3 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/uzivanie-opioidov-pocas-liecby-liekom-mysimba-moze-sposobit-vazne-neziaduce-ucinky 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-atomoxetine-sandoz-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ocaliva-kyselina-obeticholova-odporucanie-na-zrusenie-registracie-v-europskej-unii-z-dovodu-nepotvrdeneho-klinickeho-prinosu 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/sadzobnik-a-poplatky/ekolok 2026-04-01 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/ekolok/ekolok-information-for-applicants-and-users-of-the-services-of-sidc 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/ekolok/ekolok-list-of-administrative-fees-2024 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/zmena-v-uverejnovani-informacii-v-suvislosti-s-vakcinami-a-liekmi-na-covid-19 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-zadavatelov-klinickych-skusani-k-prechodu-ks-z-ctd-na-ctr 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/glatirameracetat-anafylakticke-reakcie-sa-mozu-vyskytnut-mesiace-az-roky-od-zacatia-liecby 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/ozempicr-semaglutid-aktualizacia-ohladne-dodavok-lieku-potencialna-nedostupnost 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/notice-to-users-of-the-evar-payment-portal-change-of-the-operating-mode-after-31.-08.-2024 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/zmena-uhrady-spravnych-poplatkov-cez-sluzbu-ekolok-od-1.9.2024 2026-03-20 weekly https://www.sukl.sk/en/registration-of-medicinal-product/instructions/procedure-for-payment-of-administrative-fee 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/certifikat-volneho-predaja-certificate-of-free-sale-fsc 2026-04-08 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6385 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/poplatky/spravne-poplatky-pre-klinicke-skusania-podla-nariadenia-c.-536-2014 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/ziadost-o-registraciu-distributora-zp 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2024 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2024-pozvanka-modul-2-aktuality-v-oblasti-inspekcie-a-registracie-liekov 2026-03-20 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2024/sarap-2024-modul-1 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/opatrenia-na-minimalizaciu-zavaznych-dosledkov-znameho-neziaduceho-ucinku-liekov-na-liecbu-bolesti-s-obsahom-metamizolu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/ekolok-vratenie-spravneho-poplatku 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-2.-5.9.2024 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-informuje-o-ukonceni-jarneho-zberu-liekoveho-odpadu-z-lekarni-vyzbieralo-sa-237-ton 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/nove-poziadavky-na-oznacovanie-davkovacich-inhalatorov-s-obsahom-fluorovanych-sklenikovych-plynov 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/informacie-k-podavaniu-ziadosti-podla-prechodnych-obdobi-nariadeni-eu-2023-607-mdr-a-eu-2024-1860-ivdr-suvisiace-s-narastom-poctu-podani 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/mp-133-2025-metodicky-pokyn-pre-ziadatelov-o-povolenie-na-zaobchadzanie-s-liekmi-v-druhu-cinnosti-velkodistribucia-humannych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/mp-134-2025-metodicky-pokyn-pre-ziadatelov-o-povolenie-na-zaobchadzanie-s-liekmi-v-druhu-cinnosti-vyroba-humannych-liekov 2026-03-20 weekly https://www.sukl.sk/en/clinical-trials/fees/administrative-fees-for-clinical-trials-under-regulation-no.-536-2014 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/ekolok/administrative-fee-refund-application-tl-129 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/ekolok/bank-account-affidavit 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/europska-liekova-agentura-ema-zacala-prehodnocovat-bezpecnost-liekov-obsahujucich-finasterid-a-dutasterid 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-30.9.-3.10.2024 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6423 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6424 2026-04-09 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/postregistracna-kontrola-kvality/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-trandolapril-ratiopharm-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-36.4 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/vabysmo-faricimab-pretrhnutie-primarneho-obalu-prenosovej-ihly-s-filtrom-transfer-filter-needle-tfn-ktora-je-sucastou-balenia-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/boostrix-polio-infarix-hexa-infarix-polio-problem-s-balenim-potencialne-ovplyvnujuci-sterilitu-ihiel-ktore-su-sucastou-balenia 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2024-modul-2-aktuality-v-oblasti-inspekcie-a-registracie-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/stanovisko-sukl-k-otazkam-splnomocnenca-vlady-pre-preverenie-procesu-riadenia-a-manazovania-zdrojov-pocas-pandemie-covid-19 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6431 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medsafetyweek-2024-tyzden-povedomia-o-bezpecnosti-liekov 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6434 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/pegasysr-peginterferon-alfa-2a-90-135-180-mikrogramov-nedostatocne-dodavky-injekcneho-roztoku-v-predplnenych-injekcnych-striekackach 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/aktuality/opatovna-vyzva-pre-drzitelov-registracie-liekov-na-registraciu-kontaktnych-osob-pre-dodavky-a-dostupnost-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/uzivajme-lieky-zodpovedne-rezistencia-na-antibiotika-ohrozuje-nas-vsetkych 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/vyhlasenie-ema-a-hma-odborne-dovody-podporujuce-zamenitelnost-biosimilarnych-liekov-v-eu 2026-04-15 weekly https://www.sukl.sk/o-nas/vzdelavacie-akcie-a-prezentacie/prezentacie-skolenia-a-kurzy-v-roku-2024/sarap-2024-modul-2 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/mp-141-2025-vynimky-z-uvadzania-udajov-na-vonkajsom-aj-vnutornom-obale-liekov-alebo-z-uvadzania-udajov-v-statnom-jazyku-na-obale-alebo-v-pil 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/sekcia-zp-lehota-vybavenia-ziadosti-sa-predlzila-na-viac-ako-90-dni 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/mrna-vakciny-su-bezpecne-ucinne-a-dokladne-kontrolovane 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-25.-28.11.2024 2026-03-20 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/dodatok-c.-3-ku-kontraktu-uzatvorenom-medzi-mzsr-a-sukl-na-rok-2024 2026-04-09 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lieky-s-obsahom-metamizolu-dolezite-opatrenia-na-minimalizaciu-zavaznych-dosledkov-znameho-rizika-agranulocytozy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/zmena-uradnych-hodin-podatelne-pocas-dni-23.-12.-a-31.-12.-2024 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/alofiselr-darvadstrocel-ukoncenie-registracie-lieku-v-eu-nakolko-jeho-klinicky-prinos-uz-nie-je-preukazatelnym-dovodom-pre-jeho-dalsie-pouzivanie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/zmena-legislativy-od-1.-januara-2025-preskumanie-zmien-podmienok-povoleni-na-uvedenie-liekov-na-humanne-pouzitie-na-trh 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-37.1 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/memorandum-o-spolupraci-s-faf-uk-pri-vypracovani-slovenskeho-farmaceutickeho-kodexu 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-pre-vyrobcov-zdravotnickych-pomocok-a-diagnostickych-zdravotnickych-pomocok-in-vitro-uvedene-sa-tyka-iba-vyrobcov-a-ec-rep-ov-so-sidlom-v-sr 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/nefunkcnost-telefonnych-liniek-do-17.01.2025 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-13.-16.01.2025 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/laboratorna-kontrola/pravidelny-audit-potvrdil-uspesnu-certifikaciu-sukl-v-sieti-omcl-laboratorii 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/v-roku-2024-sa-vyzbieralo-291-ton-liekoveho-odpadu.-jarny-turnus-zberu-zacina-vo-februari 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-azacitidine-accord-z-trhu 2026-04-14 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-sugammadex-amomed-100-mg-ml-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/cyanokit-hydroxokobalamin-5-g-prasok-na-infuzny-roztok-chyba-kvality-v-dosledku-moznej-mikrobialnej-kontaminacie-urcitych-sarzi-s-potencialnym-rizikom-infekcie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/dna-31.10.2025-bude-podatelna-otvorena-do-1200 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medzinarodny-den-detskej-rakoviny-moderna-liecba-a-vyzvy-do-buducnosti 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/ziadost-o-zrusenie-oznamenia-ziadost-o-zrusenie-kodu-zp-ivd-zp 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-varuje-pred-nebezpecnymi-online-vyzvami-chranme-zdravie-mladych-ludi 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6474 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/zdravotnicke-pomocky/informacie-tykajuce-sa-registracie-oznamenia-zp/formulare-oddelenia-prijmu-dokumentacie/usmernenie-k-formularom-pre-registracie-oznamenia-a-hlasenie-zmien 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/dostupnost-klinickych-skusani-liekov-v-eu-nova-mapa-dostupna-z-verejneho-portalu-ctis 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-reaguje-na-vyjadrenia-splnomocnenca-vlady 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/aktualizacia-oznamenia-k-podavaniu-hlasenia-o-reklame-liekov 2026-03-20 weekly https://www.sukl.sk/o-nas/dotazniky/vyhodnotenie-dotaznika-spokojnosti-zakaznika-za-rok-2021-az-2024 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-a-europske-liekove-autority-varuju-neregistrovane-lieky-na-inovativnu-liecbu-mozu-vazne-ohrozit-pacientov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-37.2 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-elenium-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2025-pozvanka-modul-1-aktuality-v-oblasti-registracie-liekov-a-farmakovigilancie 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-cefixim-stada-z-trhu 2026-04-14 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6493 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/ockovanie-nie-je-hrozba.-skutocnou-hrozbou-su-choroby-pred-ktorymi-nas-vakciny-chrania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/entonox-mozny-unik-plynu-a-prerusenie-dodavky-plynu-pacientovi-v-dosledku-zamrznutia-ventilu-pri-pouziti-rezimu-kontinualneho-prietoku-plynu-s-prietokom-vyssim-ako-8-l-min 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/kisqali-ribociklib-zmena-podmienok-uchovavania-a-casu-pouzitelnosti 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-atropin-bbp-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/lekarenstvo/aktualizovane-usmernenie-sool-k-overovaniu-bezpecnostnych-prvkov-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/analyza-vakcin-bude-prisne-vedecka 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/opatrenia-na-minimalizaciu-rizika-samovrazednych-myslienok-pri-liecbe-finasteridom-a-dutasteridom 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6501 2026-04-09 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/registracia-humannych-liekov/doplnujuce-pokyny-a-oznamy/usmernenie-k-uvadzaniu-hlaviciek-na-textoch-spc-pil-obl 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6506 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2025-modul-1-aktuality-v-oblasti-registracie-liekov-a-farmakovigilancie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-2.-5.6.2025 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/pridelovanie-slotov-slots-assignment 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/prihlaste-sa-na-bezplatny-webinar-edqm-europsky-liekopis-online 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/depakine-400-mg-4-ml-prasok-a-rozpustadlo-na-intravenoznu-injekciu-alebo-infuziu-aktualizacia-informacii-o-lieku-s-opravenymi-pokynmi-na-rekonstituciu-roztoku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/informacia-o-12.-vydani-europskeho-liekopisu 2026-03-20 weekly https://www.sukl.sk/o-nas/publikacie/vyrocne-spravy/vyrocna-sprava-o-cinnosti-statneho-ustavu-pre-kontrolu-lieciv-za-rok-2023 2025-06-25 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-antalerg-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/reseligo-goserelin-implantat-naplneny-v-injekcnej-striekacke-pripomenutie-spravnej-aplikacie 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-zaditen-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-upozornuje-na-biznis-s-falsovanymi-liekmi.-medzinarodna-operacia-interpolu-odhalila-alarmujuci-narast-dopytu-po-tzv.-lifestylovych-liekoch 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-7.-10.7.2025 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznamenie-pre-zadavatelov-klinickych-skusani-o-zverejneni-novej-verzie-ctis-prirucky 2026-04-08 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/telefonicke-informacie 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/mp-136-2025-oznamovanie-staznosti-alebo-reklamacii-na-nedostatok-v-kvalite-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-37.3 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-zadavatelov-klinickych-skusani 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/bezpecnostne-upozornenia/rybelsus-riziko-pochybenia-pri-podavani-lieku-v-dosledku-noveho-zlozenia-tabliet 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamovanie-zmien-tykajucich-sa-oznamovatela-zmena-nazvu-sidla-a-pod 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/registracia-lieku/metodicky-pokyn-150-2025-na-predkladanie-kvalitnych-prekladov-informacie-o-lieku 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/metodicky-pokyn-na-predkladanie-kvalitnych-prekladov-informacie-o-lieku 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/evrysdi-075-mg-ml-prasok-na-peroralny-roztok-risdiplam-chybajuci-udaj-na-obale-lieku-a-v-suhrne-charakteristickych-vlastnosti-lieku-spc-platnych-v-eu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/zypadhera-monohydrat-pamoatu-olanzapinu-210-mg-300-mg-405-mg-prasok-a-rozpustadlo-na-injekcnu-suspenziu-s-predlzenym-uvolnovanim-nedostatocne-dodavky-lieku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2025-pozvanka-modul-2-aktualne-informacie-zo-sukl.-prepojenie-registracnej-cinnosti-s-klinickym-skusanim 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/lipoplus-emu-inf-10-x-500-ml-10-x-250-ml-10-x-100-ml-sklenene-flase-r.c.-76-0269-04-s-dolezite-informacie-o-subvizualnych-aglomeratoch-pouziti-infuzneho-filtra-pre-tukove-emulzie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-varuje-pred-prudkym-narastom-ponuky-falsovanych-liekov-urcenych-na-liecbu-cukrovky-a-obezity 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/klozapin-upravene-odporucania-pre-rutinne-monitorovanie-krvneho-obrazu-z-hladiska-rizika-agranulocytozy 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-1.-4.9.2025 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/mp-149-2025-metodicky-pokyn-pre-ziadatelov-poplatnikov-spravnych-poplatkov-suvisiaci-s-vyberom-poplatkov-systemom-ekolok 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/upozornenie-pre-ziadatelov-poplatnikov-spravnych-poplatkov 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/finasterid-dutasterid-nove-opatrenia-na-minimalizaciu-rizika-samovrazednych-myslienok 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/lieky-nie-su-cukriky-sukl-upozornuje-na-zodpovedne-uzivanie-volnopredajnych-liekov 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6549 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/oznam-pre-zadavatelov-klinickych-skusani-ohladne-rocnej-spravy-o-aktualnom-stave-klinickeho-skusania 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/crysvita-burosumab-riziko-zavaznej-hyperkalciemie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/kaspofungin-kontraindikacia-pouzitia-polyakrylonitrilovych-membran-pocas-kontinualnej-renalnej-substitucnej-liecby 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/slovnik-meddra-v-slovenskom-jazyku 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2025-modul-2-aktualne-informacie-zo-sukl.-prepojenie-registracnej-cinnosti-s-klinickym-skusanim 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-37.4 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-27.-30.10.2025 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/medsafetyweek-2025-kazdy-z-nas-moze-prispiet-k-tomu-aby-boli-lieky-bezpecnejsie 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/inspekcia/aktuality/oznam-o-inspekciach-odal-pracoviska-bratislava 2026-03-20 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/klinicke-skusanie-liekov/mapa-klinickych-skusani-liekov-je-uz-dostupna-aj-v-slovenskom-jazyku 2026-04-08 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/libtayor-cemiplimab-350-mg-koncentrat-na-infuzny-roztok-cislo-sarze-a-datum-exspiracie-sa-mozu-stat-necitatelnymi-po-dezinfekcii-a-naslednom-utreti-oznacenia-injekcnej-liekovky 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/dna-17.11.-2025-bude-podatelna-otvorena-do-1200 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/pokyn-pre-verejne-a-nemocnicne-lekarne-pri-vydavani-osobitnych-povoleni-na-zaobchadzanie-s-urcenymi-latkami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/pokyn-pre-ziadatelov-o-vydanie-povolenia-na-zaobchadzanie-s-urcenymi-latkami 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6573 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/svetovy-tyzden-povedomia-o-amr-antimikrobialna-rezistencia-je-realnou-hrozbou 2026-03-20 weekly https://www.sukl.sk/o-nas/spolupraca/medzinarodna-spolupraca/europska-siet-pre-regulaciu-liekov-emrn 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/eudamed-spusta-styri-prve-moduly-pouzivanie-bude-povinne-od-maja-2026 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/planovane-ukoncenie-dodavok-vybranych-druhov-inzulinov-pacienti-a-lekari-budu-vcas-informovani-o-alternativach 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-clarithromycin-hameln-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/intravenozne-liekove-formy-kyseliny-tranexamovej-zavazne-neziaduce-reakcie-vratane-fatalnych-v-dosledku-neumyselneho-intratekalneho-podania 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/dna-23.12.-2025-bude-podatelna-otvorena-do-1200 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/keppra-100-mg-ml-peroralny-roztok-levetiracetam-riziko-chyb-v-liecbe-v-dosledku-zmeny-davkovacej-striekacky 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/europska-liekova-agentura-ema-zverejnila-svoju-prvu-vyrocnu-aktualizaciu-unijneho-zoznamu-kritickych-liekov 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/statny-ustav-pre-kontrolu-lieciv-sukl-spustil-testovaciu-verziu-noveho-webu 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/dna-31.12.-2025-bude-podatelna-otvorena-do-1200 2026-03-20 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-egoropal-z-trhu 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/drogove-prekurzory/pokyny/informacia-pre-drzitelov-povoleni-registracii-a-osobitnych-povoleni-na-zaobchadzanie-s-urcenymi-latkami 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/od-12.-1.-2026-je-podatelna-otvorena-v-beznych-prevadzkovych-hodinach-900-1200-a-1300-1400-hod 2026-03-20 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/novy-klasifikacny-guideline 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/oznamenie-o-posielani-informacie-o-vybaveni-ziadosti-namiesto-potvrdeneho-formulara 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/pharmeuropa/pripomienkovanie-clankov-europskeho-liekopisu-pharmeuropa-38.1 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/arixtra-sodna-sol-fondaparinu-zavazny-nedostatok-v-kvalite-lieku-suvisiaci-s-ihlou-v-naplnenej-injekcnej-striekacke 2026-03-20 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/upozornenie-na-aktualizaciu-mp-148-postup-pre-vystavenie-certifikatu-volneho-predaja-a-novelizaciu-tlaciva-ziadosti-o-certifikat 2026-04-01 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/bezpecnost-liekov/oznamy-drzitelov-dhpc/remsima-infliximab-nova-intravenozna-forma-100-mg-a-350-mg-koncentrat-na-infuzny-roztok-obsahuje-sorbitol-a-preto-je-kontraindikovana-u-pacientov-s-dedicnou-intoleranciou-fruktozy 2026-03-20 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/liekopis/oznamy/postup-pri-podavani-ziadosti-o-reviziu 2026-03-20 weekly https://www.sukl.sk/buxus/generate_page.php?page_id=6601 2026-04-14 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/ema-odporucila-schvalenie-prvej-kombinovanej-vakciny-proti-covid-19-a-chripke 2026-03-20 weekly https://www.sukl.sk/sekcia-nova/rubrika-vzor/podrubrika 2026-04-09 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media 2026-04-09 weekly https://www.sukl.sk/pre-odbornikov-a-firmy 2026-04-09 weekly https://www.sukl.sk/aktuality 2026-04-15 weekly https://www.sukl.sk/kontakty 2026-04-15 weekly https://www.sukl.sk/o-nas/o-sukl 2026-04-08 weekly https://www.sukl.sk/o-nas/dokumenty 2026-04-08 weekly https://www.sukl.sk/o-nas/podujatia-a-udalosti 2026-03-31 weekly https://www.sukl.sk/o-nas/publikacie 2026-04-01 weekly https://www.sukl.sk/o-nas/kariera 2026-04-01 weekly https://www.sukl.sk/o-nas/konzultacie-a-vedecke-odporucanie 2026-04-01 weekly https://www.sukl.sk/o-nas/o-sukl/hlavni-predstavitelia 2026-03-12 weekly https://www.sukl.sk/o-nas/o-sukl/posobnost 2026-04-08 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakty-medzi-mz-sr-a-sukl 2026-04-08 weekly https://www.sukl.sk/o-nas/dokumenty/archiv-dokumentov 2026-04-08 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/institucie-a-univerzity 2026-03-12 weekly https://www.sukl.sk/o-nas/spolupraca/narodna-spolupraca/odborne-zdruzenia-a-komory 2026-04-08 weekly https://www.sukl.sk/o-nas/publikacie/ostatne-publikacie 2026-04-08 weekly https://www.sukl.sk/o-nas/kariera/statna-sprava 2026-04-08 weekly https://www.sukl.sk/o-nas/kariera/verejna-sprava 2026-03-12 weekly https://www.sukl.sk/o-nas/kariera/pre-studentov 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost 2026-04-01 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/pre-media 2026-04-01 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/osvetove-kampane 2026-04-01 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sukl-v-mediach 2026-04-01 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/overenie-dostupnosti-lieku 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/registovane-internetove-lekarne 2026-03-12 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/oznamy-a-upozornenia 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/podnety 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/co-robi-sukl 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/zodpovedne-uzivanie-liekov 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/uzitocne-informacie/likvidacia-liekoveho-odpadu 2026-04-08 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/lekarne-a-vydajne-zdravotnickych-pomocok 2026-03-31 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/vyroba-distribucia-a-transfuziologia 2026-03-31 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/sadzobnik-a-poplatky 2026-04-08 weekly https://www.sukl.sk/lieky-a-pomocky/neziaduce-ucinky-liekov 2026-04-15 weekly https://www.sukl.sk/sekcia-nova/rubrika-vzor/podrubrika/pod-podrubrika-test 2026-03-24 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/sluzby-pre-verejnost/hlasenie-podozrenia-na-nedostatok-v-kvalite-lieku 2026-04-15 weekly https://www.sukl.sk/o-nas/spolupraca 2026-04-08 weekly https://www.sukl.sk/o-nas/socialne-siete 2026-04-08 weekly https://www.sukl.sk/o-nas/vyhlasenie-o-pristupnosti 2026-04-15 weekly https://www.sukl.sk/o-nas/kontakt-na-prevadzkovatela 2026-04-15 weekly https://www.sukl.sk/o-nas/zakladne-zasady-bezpecnosti 2026-04-08 weekly https://www.sukl.sk/pre-verejnost-pacientov-a-media/pre-media/medialny-servis/lieky-nie-su-cukriky-sukl-upozornuje-na-zodpovedne-uzivanie-volnopredajnych-liekov 2026-04-15 weekly https://www.sukl.sk/o-nas/dokumenty/zakladne-dokumenty/kontrakt-medzi-mz-sr-a-sukl-na-rok-2026 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/nespotrebovane-lieky-nepatria-do-kosa-ale-do-lekarne 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/english-version/about-sidc/ekolok/ekolok-methodological-guideline-for-applicants-payers-of-administrative-fees 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/konferencia-sarap-2026-pozvanka-modul-1-novinky-v-oblasti-zdravotnickych-pomocok.-prebiehajuce-zmeny-v-narodnej-legislative-zakon-362-2011 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/seminar-conforum-pozvanka-registracia-liekov-sr 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/spravne-vyplnenie-udajov-pri-registracii-hospodarskeho-subjektu-v-eudamed 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky/aktuality/pokyn-sukl-k-registracii-v-eudamed-e-a-aktualizacii-udajov-v-narodnej-databaze 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/informacie-pre-verejnost/dna-2.-4-.2026-bude-podatelna-otvorena-do-1200-hod 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/sukl-varuje-pred-nelegalnymi-automatmi-na-lieky 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/msc-holoxan-ifosfamid-1000-mg-a-2000-mg-prasok-na-infuzny-roztok-nedostatocne-dodavky-liekov 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/postregistracna-kontrola-kvality/msc-endoxan-cyklofosfamid-200-mg-500-mg-1000-mg-prasok-na-injekcny-roztok-nedostatocne-dodavky-liekov 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/bezpecnost-liekov/informacie-z-prac/zavery-z-vyboru-pre-hodnotenie-rizik-liekov-prac-7.-10.4.2026 2026-04-15 weekly https://www.sukl.sk/lieky-a-pomocky/oznamy-o-stiahnuti-liekov/stiahnutie-lieku-aknemycin-plus-z-trhu 2026-04-15 weekly https://www.sukl.sk/pre-odbornikov-a-firmy/registracia-humannych-liekov/usmernenie-k-uvadzaniu-hlaviciek-na-textoch-spc-pil-obl 2026-04-15 weekly https://www.sukl.sk/sk/zdravotnicke-pomocky-informacie/informacie-tykajuce-sa-trhoveho-dohladu-vigilancie-a-klinickeho-skusania/hlasenie-podozrenia-na-zavazne-nehody-a-neziaduce-udalosti 2026-04-15 weekly https://www.sukl.sk/hlavna-stranka/slovenska-verzia/media/tlacove-spravy/podozrenie-na-vyskyt-falsovanych-baleni-lieku-dysport-500-u 2026-04-15 weekly